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NIGHTTIME AMBULATORY PRESSURE PREDICTS 
RENAL DYSFUNCTION  
 
L van der Poel1, E Dolan1, J Duggan2 
1Hypertension and Stroke Centre, Connolly Hospital, 
Blanchardstown, 2Mater Misericordiae University Hospital, 
Dublin 7 
 
Introduction: 
Ambulatory blood pressure monitoring (ABPM) is a superior 
predictor of target organ damage when compared to clinic blood 
pressure. While the relationship between renal function and 
hypertension is well established more work is needed to clarify 
which ABPM measure predicts future kidney disease.   Our aim 
was to evaluate the relationship between baseline and follow-up 
ambulatory blood pressure and creatinine clearance (CrCl) in a 
community dwelling cohort.   
 
Methods and results: 
 3,978 patients underwent ABPM monitoring and of these, 398 
patients underwent follow up ABPM within 2 years.  Mean age 
was 64.5 years and there were 150 males.   The mean daytime 
systolic blood pressure (SBP) was 147.6 (+/-17.3) at baseline 
(Day1) and 143.6 (+/-14.74) at follow up (Day2).  The 
corresponding nighttime mean SBP was 129 (+/-19.06) (Night1) 
and 126.6 (+/- 17.05) (Night2).   Creatinine clearance (CrCl) was 
calculated at follow up and the mean CrCl was 79.8 (+/- 25.7) 
The correlation between CrCl and the 4 values are as follow:  
Day1 -0.12 (p=0.03), Day2 -0.13 (p=0.01), Night1 -0.24 
(p=0.0001) and Night2 -0.26 (p= 0.0001). In a Cox proportional-
hazard model, when adjusted for age and sex, nighttime SBP was 
a stronger predictor of CrCl at baseline (p=0.00075) and at follow 
up (p=0.03) than the corresponding daytime SBP.  There was no 
significant predictive difference between baseline and follow-up 
nighttime SBP after adjustment. 
 
Conclusion: 
Nighttime SBP appears to be a better predictor of renal function 
than daytime SBP.  Our study, in keeping with the NICE 
guidelines, shows no additional predictive benefit of follow up 
ABPM. 
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DECAFFEINATED GREEN TEA EXTRACT IMPROVES 
HYPERTENSION AND INSULIN RESISTANCE IN A RAT 
MODEL OF METABOLIC SYNDROME 
 
Sang-Hyun Ihm, Sung-Won Jang and Jae-Hyung Kim 
Division of Cardiology, Department of Internal Medicne, College 
of Cardiology, The catholic University of Korea 
 
Background: Oxidative stress and endothelial dysfunction are 
closely associated with hypertension and insulin resistance (IR) 
in metabolic syndrome (MetS). It is still controversial whether 
green tea extract (GTE) may have blood pressure (BP) lowering 
effect. Decaffeinated GTE might be presumed to have strong 
antioxidative effect and BP-lowering effect as compared with 
catechins. Thus we investigated whether decaffeinated-GTE 
could attenuate hypertension and IR by improving endothelial 
dysfunction and reducing oxidative stress in a rat model of MetS.  
Methods and Results: 20 Otsuka Long-Evans Tokushima Fatty 
(OLETF) rats at 13 weeks old, MetS rats, were randomized into 
a saline treated group (OLETF; n=10) and a group treated with 
decaffeinated-GTE (25 mg/kg/day) (GTE-OLETF; n=10). 
Intraperitoneal glucose tolerance tests and BP measurements 
were performed at 13 and 25 weeks. Decaffeinated-GTE 
significantly reduced BP (OLETF vs. GTE-OLETF; 130±7 vs. 
121±3 mmHg, p=0.01), fasting/postprandial 2 hour glucose 
(141±18/159±13 vs. 115±7/132±16 mg/dL, p=0.009/0.002) and 
insulin levels(4.8±2.3 vs. 2.4±1.3 ng/mL, p<0.001). 
Decaffeinated-GTE significantly reduced vascular reactive 
oxygen species (ROS) formation and NADPH oxidase activity, 
and improved endothelium dependent relaxation in the thoracic 
aorta of OLETF rats. Decaffeinated-GTE also suppressed the 
expression of p47 and p22 phox (NADPH oxidase subunits) in 
the immunohistochemical staining, and stimulated 
phosphorylation of endothelial nitric oxide synthase (eNOS) and 
Akt in the immunoblotting of aortas. 
Conclusions: Decaffeinated-GTE reduced the formation of ROS 
and NADPH oxidase activity and stimulated phosphorylation of 
eNOS and Akt in the aorta of a rat model of MetS, which resulted 
in improved endothelial dysfunction and IR, and eventually 
lowered BP. 
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IN VITRO VASCULAR REACTIVITY AND RESPONSE 
TO CHRONIC INHIBITION OF ALDOSTERONE IN THE 
THORACIC AORTA OF POLYCYSTIC KIDNEY 
DISEASE RATS 
 
Omar Z. Ameer1, Thamarasee M. Jeewandara1, Benjamin F. 
Wyse1, Mark Butlin1, Alberto P. Avolio1, Jacqueline K. Phillips1  
1The Australian School of Advanced Medicine, Macquarie 
University, Sydney, NSW, Australia.  
 
Objectives: Chronic kidney disease (CKD) is associated with 
changes in vascular endothelial and smooth muscle function. 
Aldosterone has been implicated in altered endothelial function 
and enhanced smooth muscle contractile responses.  We have 
previously shown elevated aldosterone levels in Lewis polycystic 
kidney disease (LPK) rats.  We therefore aimed to determine 
vascular reactivity in the LPK and the effect of treatment with an 
aldosterone antagonist. 
 
Methods: LPK and Lewis were treated with spironolactone 
(20mg/kg/day p.o.) or diluent from 4-12 weeks old (mixed sex, 
total n=41). Thoracic aortic rings were used to construct 
cumulative concentration-responses to noradrenaline (NA, 
1.0×10-10–3.0×10-4M) and potassium (KCl, 5–100mM) to 
investigate vascular contractility. Relaxation was investigated in 
phenylephrine (PE, 1µM) pre-contracted aortic rings, testing 
endothelium-dependent and -independent responses to 
acetylcholine (ACh, 1.0×10-10–1.0×10-5M) and sodium-
nitroprusside (SNP, 1.0×10-11–1.0×10-6M), respectively. 
 
Results: There was a leftward shift in the concentration-response 
curves to NA and KCl (maximum - NA: 1.0±0.1 vs. 1.7±0.1g, 
KCl: 1.0±0.1 vs. 1.6±0.1g, LPK vs. Lewis, P<0.001), indicating 
increased sensitivity and reduced compliance of LPK aortic rings. 
Vasodilatation mediated by ACh and SNP was significantly 
impaired (ACh at 1.0×10-5M: 50±8 vs. 82±6%, SNP at 1.0×10-
6M: 69±10 vs. 99±1%, LPK vs. Lewis, P<0.001), suggesting 
endothelial dysfunction and decreased vessel compliance, 
respectively. Spironolactone pretreatment did not significantly 
improve vasoconstrictor responses nor ACh- and SNP-mediated 
relaxation in the LPK. 
 
Conclusions: LPK demonstrated impaired vascular reactivity that 
was not improved after treatment with spironolactone. 
Aldosterone is therefore not likely driving vascular stiffness or 
impaired endothelial function in this model of CKD. 
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INCREASED PREVALENCE OF ESSENTIAL 
HYPERTENSION IN YOUNG ADULTS WITH HIGH 
HETEROPLASMY LEVELS OF THE MELAS M.3243A>G 
MUTATION  
 
Fady Hannah-Shmouni,1 Sandra Sirrs,2  Michelle M. Mezei,3 
Paula J.  Waters,4 Andre Mattman5 
 
Vancouver General Hospital/University of British Columbia: 
Adult Metabolic Diseases Clinic, Division of Endocrinology1,2,3,5. 
Division of Neurology3. Department of Pathology & Laboratory 
Medicine 4,5 
 
Background: Growing evidence exists linking mitochondrial 
DNA1, its mutations2, and mitochondrial dysfunction3 to the 
pathogenesis of hypertensive disease. No reports on the 
prevalence of hypertensive disease in adult patients with 
confirmed mitochondrial diseases (mitoD) have been described. 
 
Methods: We performed a retrospective chart review of adult 
patients with mitoD between January 1999 and January 2012 at 
our center. We grouped them into age categories to allow 
comparison with previously reported Canadian Health Measures 
Survey (CHMS)4 prevalence data.  
 
 
Age 
catego
ry, 
years 
mitoD CHMS* 
 
p-value** 
Non-
hyperte
nsive 
Hypert
ensive 
Non-
hyperte
nsive 
Hypert
ensive 
20-39 4 5 1,152 33 <0.0001 
40-59 20 6 996 238 0.63 
60-79 11 12 502 593 0.85 
 
Table 1. Sample size: Canadian Health Measures Survey 
(CHMS)4 vs. hypertensive and non-hypertensive patients with 
mitoD. 
 
 
*Canadian Health Measures Survey (CHMS)4. 
** The prevalence within each category was compared with 
CHMS data4 using Chi squared analysis with a confidence 
interval of 95%. 
 
Results: 23 subjects with hypertensive disease were identified for 
a crude prevalence of 39.7% (95% CI 27–53%) as compared to 
the CHMS4 age predicted prevalence of 30.5%. When analyzed 
by individual age group, there were no significant differences 
between the observed and the CHMS4 predicted prevalence rates 
in the 40 years and older cohorts (age category 40-59, p=0.63; age 
category 60-79, p=0.85). However, the hypertensive disease rates 
were significantly higher than predicted in the under 40 years 
cohort (55.6 vs. 2.8%, p<0.001, CI 21–86%), in which 
hypertensive patients with the MELAS m.3243A>G mutation 
were significantly clustered (p<0.01). This younger MELAS 
cohort (n=4, mean age=24 years) with essential hypertension had 
heteroplasmy levels (mean=68%) that were significantly higher 
than the levels found in the older non-hypertensive MELAS 
cohort (n=8, mean age=52 years, mean=33%) (p=0.04). 
 
Conclusion: Relative to age, gender and mitoD subtype, young 
adults with high heteroplasmy levels of the MELAS m.3243A>G 
mutation demonstrates an increased prevalence of essential 
hypertension. Further prospective data are needed to confirm this 
initial finding, which has potentially important treatment 
implications5. 
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INCREASED INTRINSIC STIFFNESS OF AORTIC 
VASCULAR SMOOTH MUSCLE CELLS; A NOVEL 
MECHANISM FOR HYPERTENSION 
 
Hongyu Qiu1, Nancy L. Sehgel
1,2, William C. Hunter1,2,  Stephen 
F. Vatner1, , Gerald A. Meininger
3, Dorothy E. Vatner,1 
1Department of Cell Biology and Molecular Medicine, UMDNJ-
New Jersey 
Med School, Newark, NJ.  
2Department of Biomedical Engineering, New Jersey Institute of 
Technology, Newark, NJ. 
3Dalton Cardiovascular Res Center and Department of Medical 
Pharmacology and Physiology, Univ of Missouri, Columbia, MO.  
 
Objectives: An increase in vascular stiffness is a fundamental 
component of hypertension, which has been thought to be 
mediated by changes in the extracellular matrix (ECM). Our 
hypothesis, that increased arterial stiffness in hypertension is due 
in part to intrinsic mechanical properties of vascular smooth 
muscle cells (VSMC), has not been examined previously.    
Methods and Results: Adult spontaneously hypertensive rats 
(SHR) (16 weeks old) and age-matched Wistar-Kyoto 
normotensive (WKY) rats were studied.  Aortic pressure was 
higher in SHR than WKY (mean arterial pressure 123±4 versus 
96±6 mmHg, p<0.05). Aortic stiffness (pulse wave velocity) was 
also higher in SHR (7.65 mm/ms) vs. WKY (3.27 mm/ms, 
p<0.01). Aortic VSMCs stiffness was continuously recorded 
using atomic force microscopy (AFM), and temporal oscillations 
in VSMC elasticity, which represent the dynamic properties of 
elasticity, were observed and analyzed by Eigen decompensation. 
VSMC stiffness was consistently increased in SHR (24.0 kPa) vs 
WKY (11.8 kPa) (p<0.05). The oscillations in elasticity were 
significantly different between the two groups in terms of 
frequency and amplitude (p<0.05). ML-7, a highly specific 
inhibitor of myosin light chain kinase (MLCK), produced a 
greater reduction in the VSMC elasticity from SHR aorta 
compared to WKY rats (p<0.05).  Furthermore, ML-7 altered the 
oscillations in VSMC elasticity in SHR, but not WKY.   
Conclusions: Thus, increased vascular stiffness in hypertension 
occurs not only at the level of the ECM, which has been 
recognized for some time, but also in VSMCs, a concept not 
considered previously. 
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TOBACCO DEPENDENCY AMONG URBAN KNOWN 
HYPERTENSIVE VERSUS NON-HYPERTENSIVE 
CIGARETTE SMOKERS – A COMMUNITY BASED 
STUDY AT KARACHI, PAKISTAN 
 
Ranomal Kotak1, Rozina Mistry1, Intisar Ahmed2 
1Community Health Directorate, Aga Khan Health Service, 
Pakistan, 2College of Physicians and Surgeons, Pakistan  
 
Objective: To compare tobacco dependency using ‘Fagerström 
Nicotine Dependence Scale’ among hypertensive patients versus 
non-hypertensive cigarette smokers in Karachi, Pakistan. 
 
Methods: Randomized cross-sectional population based survey 
was conducted in  Karachi from November 2008 to January 
2009.The ‘Fagerström Nicotine Dependence Scale’ was 
administered after translation in Urdu and pre-testing to collect 
the data from eligible study subjects of age 15 to 69 years who 
reported as current smokers. Frequencies and independent 
samples t-test were used for analysis through SPSS 11.5. 
 
Results: There were 2006 study subjects including 92 (4.6%) who 
reported as current smokers. Mean age (SD) for smokers in study 
was 45.2+13.2. All subjects reporting as smokers were male and 
reported known cases of hypertension among smokers were 
26.8% (n=92). Average Fagerström Test for Nicotine 
Dependence (FTND) score was 2.6 + 2.5 (n=89) among current 
smokers. It was observed that the significant tobacco dependency 
(FTND Score > 5) among hypertensive and non-hypertensive 
were 29% (n=17) and 21% (n=72) respectively. However there 
was no significant difference between both groups (p value = 
0.731; CI 95%).  
 
Conclusion: The prevalence of smoking in this study in urban 
Pakistan was reported low as compared to previous studies. 
However tobacco dependency among hypertensive and non- 
hypertensive subjects was high without significant difference.  It 
is important to formulate community based strategy for quitting 
tobacco smoking at mass level. 
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REGULATIONS OF HYPERTENSION AND 
CHOLESTEROL METABOLISM BY FRUIT VINEGAR 
BEVERAGES 
 
H.M.A. Ruchira Nandasiri1, H.P. Vasantha Rupasinghe1, Yanwen 
Wang2 
1Department of Environmental Science, Nova Scotia Agricultural 
College, P.O. Box 550, Truro, Nova Scotia, Canada B2N 5E3 
 2Institute for Nurtisciences and Health, National Research 
Council Canada, 550, University Avenue, Charlottetown, PE, 
Canada C1A 4P3  
 
Background & Objectives: An elevated level of blood cholesterol 
levels are positively correlated with hypertension and 
cardiovascular diseases. Higher intake of cholesterol levels by 
food has been proven to result cardiovascular diseases and 
hypertension. Even though, currently there are treatments to 
control the above diseases people would prefer to rely on the 
natural health products. Fruit vinegar beverages has been 
introduced to the North American market as a functional beverage 
and shown its ability to reduce the blood pressure levels. The 
present study was carried out to investigate the effects of four 
different vinegar beverages, on in-vivo hypertension and 
cholesterol metabolism. 
 
Design and methods: Seventy-two spontaneously hypertensive 
rats (SHR) were housed in individual cages. After seven days of 
adaptation, they were grouped in to six groups including two 
controls and four treatment groups (apple, blueberry, cranberry 
and tomato) and fed an AIN-93G diet with addition of 2% 
cholesterol for four weeks. Treatments were given to SHR by 
gavage feeding method. 
 
Results: After four weeks blueberry vinegar beverage was able to 
reduce to the diastolic blood pressure levels of the rats (P<0.05). 
Serum TC levels and triglyceride levels of control group was 
significantly different (P<0.05) from the treatment groups. 
Blueberry and apple vinegar beverages resulted higher serum 
High Density Lipoprotein (HDL) values (P<0.05) compared to 
the control group. Body weight of the control group was 
significantly different (P<0.05) from the treatment groups after 
four weeks of study. 
 Conclusions: In conclusion fruit vinegar beverages were able to 
reduce the blood pressure levels and regulate the serum 
cholesterol levels of SHR. 
 
185 
NUTRITIONAL STATUS & BODY COMPOSITION OF 
NORMAL VS. HYPERTENSIVE ADULT POPULATION 
Rita Singh Raghuvanshi1, Lotika Barakoti1, Priyanka Singhal1 
1G. B. Pant Univ. of Agri. & Tech., Pantnagar, Uttarakhand, 
India 
 
Objectives & Background: To find out variation in nutritional 
status and body composition of normal vs. hypertensive subjects.  
 
Designs & methods: A total of 200 participants i.e.100 normal 
and 100 hypertensive aged 30-70 years were selected randomly. 
Nutritional status was assessed through stature, weight, mid upper 
arm circumference, waist to hip ratio, triceps, biceps, sub-
scapular, supra-illiac, and BMI using standard procedures. Body 
composition by Bioelectrical Impedance Analysis (BIA) 
estimated fat mass, fat free mass, body water. Blood pressure of 
all subjects was taken.  
 
Results: Blood pressure values were found to be statistically 
significant different (p<0.05) among normal and hypertensive 
subjects. The difference for MUAC, biceps and waist 
circumference was observed to be statistically significant 
(p<0.05) among both groups.  For BMI, no significant difference 
(p>0.05) was seen among both groups among males while among 
females significant difference (p<0.05) has been observed among 
both groups. Pertaining to body composition analysis a significant 
difference (p<0.05) was appeared for % fat and % total body 
water among both groups. Higher fat % was present among 
hypertensive population than normal ones. More fat % was 
present among females than males. Higher values of extracellular 
water (%) and intracellular water (%) has been found among 
normal group as compared to hypertensive group. For this, a 
statistical difference was found. 
 
Conclusions: Body fat % was found to be higher and body water 
was lower among hypertensive group than normal ones. 
Therefore, body composition assessment may provide better 
information on likelihood of developing chronic diseases in future 
than BMI.  
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RELATION BETWEEN LOW LEVEL OF THE 
DOPAMINE EXCRETION AND PERSISTENT BLOOD 
PRESSURE ELEVATION IN PATIENTS WITH 
ABDOMINAL OBESITY 
 
Lizogub1 V., Voloshyna O. 1, Dolynna O. 1, Lyzogub G. 1 
O.O Bogomolets National Medical University, Kyiv, Ukraine 
 
Objective: Recent research data suggest that dopaminergic 
system influence on angiotensin and blood pressure (BP) 
regulation.  We have studied possible relation between arterial 
hypertension(AH), low dopamine excretion rate (DER) and 
abdominal obesity (AO). 
Design and methods: In our study there were 118 patients with 
previously untreated mild to moderate AH (men – 63(53.3%) , 
mean age 44,7±2,6 years. 72 patients had AO with BMI range 30-
40kg/m2. Depending on DER all patients have been divided into 
two groups. First group was consisted of 48 patients with low 
DER, second – 70 patients with DER within normal for age limits 
(800-1000 mmol/l). All patients of group 1 and 29 in group 2 had 
AO.   
Results: In all patients we measured aldosteron (A), angiotensine-
II (AT-II), prolactine (Pr), leptine (Lep) and DER in urine.  
Patients of the first group have demonstrated positive relation 
between A level and BMI (r=0,5; Р<0,001), Pr level and BMI 
(r=0,57; Р<0,001) and negative relation between concentration of 
A, A-II, Pr and DER (r=-0,32; r=-0,41; r=-0,33, respectively; all 
Рs<0,01,).  In patients with normal DER (second group) there 
were no changes in Pr and A levels, and increased levels of AT-
II. However patients with AH and AO with normal DER have 
demonstrated rise in Lep levels as well.  
Patients of the first group were receiving as antihypertensive 
treatment selective D2-reseptor agonist bromcriptin or agonist of 
D1,D2,D3,D4 receptors –pramipexole. After 4 weeks of 
treatment BP, DER (186,4% rise) and A level (49,5% fall) have 
reached normal limits.   
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PREVALENCE OF HIGH BLOOD PRESSURE IN 
SCHOOL CHILDREN IN UAE 
 
Emadullah Shafi, Ebadullah Shafi, Abeer Rehman, Quratulann 
Rahat 
RAK Medical & Health Sciences University, United Arab 
Emirates 
 
Introduction: Hypertension is a major health problem in 
developed and developing countries. Early identification of 
children at risk for hypertension is important to prevent serious 
complications. 
 
Objectives: (1) To evaluate the relationship between body mass 
index (BMI), dietary habits, exercise pattern and the tendency of 
developing hypertension in school children and (2) To analyze the 
awareness of hypertension, associated life style and related 
diseases among students in schools of UAE. 
 
Materials & Methods: A cross-sectional study among 575 school 
children, selected by random sampling was conducted in schools 
of UAE.Personal data and related information was collected 
through a pre-tested questionnaire. Blood pressure, weight and 
height was measured through standardized techniques and 
quetelet index used to determine BMI. Statistical analysis was 
done using SPSS 17 software.  
 
Results: Blood pressure of children showed positive correlation 
with anthropometrics characteristics. In our study 28% of 
children were in pre-hypertensive stage, 10% had BP in range of 
140/90-159/99mmHg. 59% of the children were in overweight 
category and 54% were obese. 49% of children who were not 
doing any exercise had high BP. 55% of overweight children had 
high BP and 44 % eating fast food also had high BP .It was seen 
in our study that 63% of children were not aware of risk factors 
associated with high BP and its preventive measures. 
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EFFECTS OF BRIEF EXPOSURE TO A HIGH-SALT DIET 
IN DAHL SALT-SENSITIVE RATS: EVIDENCE FOR 
‘SALT MEMORY’ DURING HYPERTENSION 
DEVELOPMENT 
 
Kimiko Ishiguro, Hiroyuki Sasamura, Mari Nakamura, Hideyo 
Oguchi, Kaori Hayashi, Tatsuhiko Azegami, Hiroshi Itoh  
 
Objectives: We and others have shown that treatment of SHR or 
Dahl salt-sensitive rats with renin-angiotensin-aldosterone 
(RAA) system inhibitor at the time of hypertension development 
causes a sustained reduction of blood pressure. The aim of this 
study was to examine the effects of temporary exposure to a high-
salt diet on blood pressure and markers of end-organ damage in 
Dahl salt-sensitive rats. 
 
Methods: Dahl salt-sensitive rats (n=24) were divided into 4 
groups, and fed from age 6 to 14 weeks with low-salt 
(0.12%NaCl), normal-salt (0.8%NaCl) high-salt (7%NaCl) or 
high-NaAA (12.7%NaAA, containing high-sodium alone) diet. 
After these treatments, all group were returned to a normal-salt 
diet. The effects on systolic blood pressure and urine albumin 
excretion were examined regularly until age 28 weeks.  
 
Results: Transient treatment with a high-salt diet caused an 
elevation in blood pressure not only during the treatment period, 
but also after returning to the normal-salt diet. 3 months after 
treatment cessation, blood pressures were still elevated in the rats 
transiently exposed to a high-salt diet (Control: 146±10mmHg, 
high-salt 198±9**, p<0.01). Similarly, urine albumin excretion 
was elevated in the high-salt rats at the end of the study. No such 
effect was seen in the NaAA group. At age 28 weeks, the high-
salt group rats demonstrated increases in plasma renin activity, 
aldosterone, with a similar trend for renal renin mRNA. 
 
Conclusion: These results suggest that transient high-salt diet 
treatment results in a sustained elevation of blood pressure and 
activation of RAA system in Dahl salt-sensitive rats.  
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THE MICROCIRCULATION (CAPILLARY) 
HYPOTHESIS OF “ESSENTIAL” HYPERTENSION AND 
THE BALANCE EQUATION OF BLOOD PRESSURE 
REGULATION ARE SUPPORTED BY EVIDENCE 
SHOWING CARDIO-RENAL INTERACTION IS 
ENDOTHELIUM DEPENDENT 
 
John B. Myers1 
1Well-spring's Universal Environment. 
 
Background: It has been appreciated that renal function actively 
affects cardiac dynamics whereas the heart has been thought of as 
a passive (pre-renal) bystander in the renal-cardiac dynamic. 
Ochodnick et al(1) have shown that proteinuria and focal 
glomeruloscerosis is predicted by renal interlobular arteriolar 
endothelial response to Acetylcholine in uninephrectomised rats 
subjected to left coronary artery ligation, indicating the 
importance of endothelial function. 
 
Objective: To utilize the above evidence to support the 
microcirculation hypothesis of “essential hypertension”(2,3) 
which proposes that efferent arteriolar tone in the kidney and pre-
venular arteriolar tone systemically act to control filtration 
fraction and capillary flow to maintain right atrial pressure, which 
is an exaggeration of the physiological circulatory functional 
arrangement(4) (cardio-renal interaction) controlling body 
sodium and fluid. 
 
Results: The outcome that glomerulosclerosis and proteinuria in 
uni-nephrectromised rats with myocardial infarction was 
predicted by endothelial function in interlobular arteries supports 
the hypothesis of the primary role of capillary endothelium in the 
cardiac-renal interaction as glomerulosclerosis and proteinuria 
are capillary, i.e. endothelial effects that relate to arteriolar 
function and atrial stretch as conceptualized in the Balance 
Equation of Blood Pressure Regulation(4) and the 
microcirculation hypothesis of “essential” hypertension(2,3). 
 
Conclusions: Demonstration of a connection between the heart 
and the kidney based on endothelial function supports the 
microcirculation hypothesis of “essential hypertension” and of 
capillaries in the physiology of sodium and fluid homeostasis 
afforded by cardio-renal interaction. 
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THE ROLE OF CAPILLARY INTEGRITY, FLUID 
DISTRIBUTION AND THUS ATRIAL FILLING 
PRESSURE AND FORGOTTEN RED CELLS IN SODIUM  
SENSITIVE (DIASTOLIC BLOOD PRESSURE 
RESPONSIVE) SUBJECTS 
 
John B. Myers1 
1Well-spring's Universal Environment 
 
Background: The role of the micro-circulation and angiogeneneis 
inhibition has recently been recognised(1), but the role of the 
micro-circulation, fluid distribution and red cells and 
pathophysiology of sodium sensitivity in addition to altered renal 
sodium handling has been forgotten(2,3).  
Study Design: The randomised effect of sodium intake was 
studied in 117 subjects (1mmol/kg/day vs. 3mmol/kg/day) for 
two weeks following a run-in period(4). 
Results:  Weight gain was mildly inversely related to reduced 
CrCl as measured on the reduced sodium diet but did not differ 
between patients in whom HCT rose when sodium intake was 
increased (n=43) and in those in whom HCT fell (n=74). In these 
patients plasma sodium increased on the high sodium diet but 
blood pressure did not change, whereas in subjects in whom HCT 
rose with increased sodium intake plasma sodium did not change 
but diastolic blood pressure rose. 
Conclusions: Fluid distribution towards the extravascular 
compartment plus into red cells with diminution of the plasma 
compartment explains the findings as weight change did not differ 
between groups. The findings indicate that red cells are an 
important buffer to the rise in plasma sodium that accompanies 
an increase in sodium intake in sodium sensitive subjects. The 
effect of fluid shifts that raise atrial filling pressure is the dynamic 
factor to which the rise in arteriolar tone is secondary, not primary 
and acts as a negative feedback to the raised right atrial filling 
pressure through control of systemic capillary flow and renal 
mechanisms enhancing glomerular filtration in sodium sensitive 
subjects. 
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‘SALT MEMORY’ OF HYPERTENSION IN 
SPONTANEOUSLY HYPERTENSIVE RATS (SHR) 
REQUIRES BOTH SODIUM AND CHLORIDE IONS. 
 
Hideyo Oguchi, Hiroyuki Sasamura, Kimiko Ishiguro, Kaori 
Hayashi, Mari Nakamura, Tasuhiko Azegami, Hiroshi Itoh 
Department of Internal Medicine, School of Medicine, Keio 
University, Tokyo, Japan. 
 
Objective: We have recently reported that brief exposure of Dahl 
salt-sensitive rats to a high-salt diet at the time of hypertension 
development causes a sustained increase of blood pressure. The 
aim of this study was to examine the presence of this ‘salt 
memory’ 
of hypertension in SHR, and the contribution of sodium and 
chloride ions to this effect. Methods: Male SHRs (n=30) were 
divided into five groups, and fed during an early stage of 
development (from age 6 to 14 weeks) with a low-salt (0.12% 
NaCl), normal-salt (0.8% NaCl) or high-salt (7% NaCl) diet. 
Other rats were given a high-sodium/normal-chloride (12.7% 
NaAA) or normal-sodium/high-chloride diet 
(11.6% AACl). After these treatments, all groups were returned 
to a normal-salt diet. The effects on systolic blood pressure and 
urine albumin excretion were examined regularly until age 24 
weeks. Results: Transient treatment with a high-salt diet caused 
an elevation in blood pressure not only during the treatment 
period, but also after returning to the normal-salt diet, suggesting 
the presence of ‘salt memory’ in SHR. No such effect was seen in 
rats treated with high-sodium alone or high-chloride alone. An 
increase in proteinuria and renal arteriolar hypertrophy was 
recognized in the high salt group, together with a marginal 
elevation in renin-angiotensin-aldosterone (RAA) system 
activity. Conclusion: These results show that transient high 
dietary salt induces a sustained elevation of blood pressure, 
suggesting the presence of ‘salt memory’ in SHR. Both sodium 
and chloride ions were found to be essential for the development 
of this memory phenomenon. 
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GPCR STIMULATED HYPOTHALAMIC PVN GαI2 
PROTEIN-GATED PATHWAYS – THE KEY TO RENAL 
SYMPATHETIC NERVE MEDIATED SODIUM 
HOMEOSTASIS AND THE LONG-TERM CONTROL OF 
BLOOD PRESSURE 
 
Richard Wainford1 
1Boston University School of Medicine Department of 
Pharmacology & Experimental Therapeutics and Cardiovascular 
Medicine and the Whitaker Cardiovascular Institute 
 
Aim:  
We have demonstrated CNS Gαi2 proteins, which are highly 
expressed in the hypothalamic PVN, mediate the renal 
sympathoinhibition and natriuresis evoked by α2-adrenoceptor 
activation and volume expansion in-vivo. Therefore, we 
examined the role(s) of PVN Gαi2 proteins in fluid & electrolyte 
homeostasis and MAP regulation following elevated dietary salt-
intake. 
 
Methods:  
Intact or bilateral renal denervated (RDNX) Sprague-Dawley rats 
received a bilateral PVN or posterior hypothalamic (PH) infusion 
of a scrambled (SCR) or Gαi2 oligodeoxynucleotide (ODN-
300ng/side/day) and a normal 0.4% (NS) or high 8% NaCl (HS) 
diet for 7-days. On day-7 MAP, 24h metabolic balance, plasma 
norepinephrine, (NE) and PVN Gαi2 protein levels were 
determined (N=5/group). 
 
Results:  
HS-intake evoked a significant 3-fold site-specific increase in 
PVN Gαi2 proteins. ODN-mediated PVN Gαi2 down-regulation, 
but not PH miss-injection or PVN SCR ODN pre-treatment, 
caused renal nerve-dependent sodium retention (24h Na+ balance 
[meq] PH Gαi2 + HS 0.5±0.2, PVN Gαi2 + HS 2.3±0.4*, PVN 
Gαi2 RDNX + HS 0.8±0.3τ), global sympathoexcitation (plasma 
norepinephrine [nmol/L] PH Gαi2 + HS 17±4, PVN Gαi2 + HS 
75±9*, PVN Gαi2 RDNX + HS 24±6
τ) and hypertension (MAP 
[mmHg] PH Gαi2 + HS 128±3, PVN Gαi2 + HS 140±2*, PVN 
Gαi2 RDNX + HS 131±3
τ) *p<0.05 vs. PH Gαi2 + HS, 
τp<0.05 vs. 
PVN Gαi2 + HS.  
 
Conclusion:  
Renal nerve dependent dysregulation of sympathetically driven 
sodium retaining mechanisms occurred following PVN Gαi2-
protein down-regulation evoking salt-sensitive hypertension. We 
conclude PVN Gαi2 protein-gated pathways regulate renal nerve-
dependent sodium excretion to facilitate sodium homeostasis and 
maintenance of a salt-resistant phenotype – R01HL107330. 
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Using complex system entropy method of data mining 
on biomedical pattern of essential hypertension: a 
survey of the literature  
WANG Juan1, ZHAO Huihui1, CHEN Jianxin1, MA Xueling1, 
XU Xuegong1, LUO Liangtao1, LI Yubo1,ZHANG Li1,WANG 
Wei1  
1Beijing University of Chinese Medicine, Beijing 100029, China  
Background: Complex system entropy method of data mining is 
a technique for discovering useful information hidden in related 
databases, which has recently been used by medical, chemical and 
Pharmaceutical industries. It may enable us to detect the 
interesting and hidden biomedical patterns in the field of 
cardiovascular disease, and reveal potential biological 
mechanisms underlying essential hypertension(EH).  
Methods: We summarized 597 experimental and clinical studies 
linking with EH and evaluated the related physicochemical 
indexes, the most related physicochemical indexes and their 
complicated correlations were figured out using a complex 
system entropy method of data mining.  
Results: By analysis and calculation of published data, the top 
twenty physicochemical indexes were ranked by the incidence 
coefficient, including 24 hour blood pressure, left ventricle 
ejection fraction, heart rate viability, followed by urea acid, lipid 
protein, triglyceride, SOD,etc. These findings agreed with 
evidence accumulated from previous studies. Given that urea acid 
is an important cardiovascular risk factor, there is the potential for 
an increased risk that accelerates the development of essential 
hypertension. Besides that, it was found that these multiple 
biochemical changes also indicated dyslipidemia, kidney 
dysfunction and oxidative stress associated with the severity of 
EH, suggesting the possibility of new treatment of EH.  
Conclusion: Complex system entropy method of data mining had 
been an appropriate and sufficiently sensitive method to analyze 
the biomedical mechanisms underlying EH. These 
physicochemical indexes may play an discriminate role in the 
patho-physiology of EH and could provide important targets for 
pharmaceutical interventions. 
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ALDOSTERONE AND RESISTIN ARE RELATED WITH 
PATHOPHYSIOLOGY OF RESISTANT HYPERTENSIVE 
 
Silvia Ferreira-Melo   
 
Background: Obesity has been associated with resistant 
hypertension (RHTN) by high aldosterone and adipocytokines 
plasma levels. Resistin is a hormone produced by adipocite tissue 
implicated in endothelial dysfunction and vascular stiffness in 
hypertensive subjects. However, the role of both aldosterone and  
resistin  in the development of resistant hypertension is not clearly 
understood. Methods: Office BP, aldosterone and resistin plasma 
levels (ELISA), endothelial function (brachial flow-mediated 
dilation, FMD) and vascular stiffness (pulse wave velocity- 
PWV) were evaluated in 93 RHTN patients. Pearson´s correlation 
was used to analyze the association between aldosterone and 
resistin with the other variables. Results: RHTN patients had 
(mean±SD): age (58.0±10.8 y.o.), BMI (30.89±4.83kg/m2), 
Systolic BP (SBP) (147±17mmHg), Diastolic BP (DBP) (87±11 
mmHg), PP (60±15 mmHg), aldosterone levels (119.5±66.8 
pg/mL), resistin levels (11.4±5.8 ng/mL), FMD test response 
(7.8± 1.8%) and pulse wave velocity (PWV= 11.5±1.8 m/s). 
Aldosterone plasma levels correlated with SBP (p< 0.001; 
r=0.41), PP (p< 0.001; r=0.35), FMD response (p< 0.05; r= -
0.23),  but not resistin (p>0,05). Both resistin and aldosterone 
plasma levels correlated with PWV (p< 0.05; r=0.32;  p< 0.001; 
r= 0.43, respectively). Conclusion: Despite the importance of 
resistin in endothelial dysfunction in RHTN, aldosterone may 
surpass the importance of this adipocytokine in resistant 
hypertension pathophysiology, playing an important role in the 
mechanisms of antihypertensive therapy resistance. 
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EFFECT OF SODIUM RESTRICTION ON DOSE OF 
CAPTOPRIL IN PATIENTS WITH SEVERE 
HYPERTENSION UNCONTROLLED ON THERAPY 
 
John B. Myers1 
1Well-spring's Universal Environment 
 
Background: Though presented at the first ACE (Angiotensin 
Converting Enzyme) inhibitor meeting in Milan in 1981 this 
study, with Morgan TO and Waga S, was not published in 
proceedings as the editors' view was that it was poorly written and 
time did not permit a rewrite, remains a landmark report 
demonstrating the effectiveness of salt restriction as a renin-
angitensin modifying strategy that potentiates the effectiveness of 
oral ACE inhibitor therapy. 
Study Design: 9 adult patients (8 males) with previously 
uncontrolled severe hypertension despite treatment with other 
than an ACE inhibitor were treated with the first orally active 
ACE inhibitor, Captopril and sodium restriction plus other drugs 
including Frusemide. 24h urinary sodium excretion was used as 
the mesaure of sodium intake. 
Results: Average sodium intake (2-3mmol/kg/day) was reduced 
to <1mmol//kg/day. Captopril dose titration permitted average 
doses of around 37.5mg tds in sodium restricted patients 
compared to the recommended 150mg tds. Addition of Lasix 
40mg stabilised the blood pressure response. Ageusia in 3 patients 
helped to reduce sodium intake. All males responded to the 
combination above, while one also required Prazosin and a 
Calcium channel blocker and emergency saline infusion because 
of severe hypotension on the reduced sodium intake (20-
30mmol/day). The female patient did not respond to ACE plus 
sodium restriction but did respond to several drugs of which alpha 
methyl Dopa was the most effective given tds. 
Conclusions: Reduced sodium intake permits blood pressure 
control with lower doses of ACE inhibitor and is recommended 
as first line treament in male patients. 
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ABDOMINAL OBESITY, RENIN-ANGIOTESIN-
ALDOSTERONE SYSTEM ACTIVITY AND COMMON 
CAROTID ARTERIES INTIMA-MEDIA THICKNESS 
 
Bazhenova E.., Belyaeva O., Berezina A., Kolodina D., 
Naneishvili T., Karonova T., Ivanova T., Berkovich O., Baranova 
E., Shlyakhto E. 
 
Almazov Federal Centre of Heart, Blood and Endocrinology, I.P. 
Pavlov State Medical University 
 
Aim. Abdominal obesity (AO) leads to increasing of RAAS 
activity and common carotid arteries intima-media thickness 
(CCA IMT). 
Material and methods. We studied 285 patients (47.3±0.6) with 
AO (IDF, 2005) and 30 non-obese (NO) subjects. 52,1% of obese 
patients had  
arterial hypertension (AH). 29.1% of obese patients had 
atherosclerotic plaques (AP) in CCA. Plasma renin activity 
(PRA) investigated by radioimmune assay, CCA IMT -  by 
ultrasound duplex scan.  
Results. PRA and CCA IMT were higher in obese patients versus 
NO subjects (PRA: 4.0±0.7 and 2.0±0.7 ng/ml/h, p=0.03; CCA 
IMT left: 1.1±0.3 and 0.6±0.01cm, p=0.0001; CCA IMT right: 
0.8±0.01and 0.6±0.02 cm; p=0.0001). PRA and CCA IMT were 
higher in obese patients with AH versus obese patients without 
AH (PRA: 6.0±1.3 and 1.7±0.2 ng/ml/h, p=0.0001; CCA IMT 
left: 1.3±0.6 and 0.2±0.02 cm, p=0.0001; CCA IMT right: 
0.9±0.02 and 0.7±0.01 cm; p=0.0001). PRA and CCA IMT were 
higher in obese patients with AP in CCA versus obese patients 
without AP in CCA (PRA: 8.3±3.8 and 2.6±0.5 ng/ml/h, p=0.04; 
CCA IMT left: 1.9±0.9 and 0.7±0.01cm, p=0.0001; CCA IMT 
right: 1.0±0.03 and 0.7±0.01 cm; p=0.0001). We revealed 
correlations between PRA and CCA IMT (r=0.2; p=0.03), waist 
circumference (WC) (r=0.1; p=0.04), systolic blood pressure 
(SBP) (r=0.3; p=0.001), diastolic BP (DBP) (r=0.2; p=0.002), 
duration of obesity (r=0.2; p=0.03); and between CCA IMT and 
BMI (r=0.4; p=0.001), age of patients (r=0.4; p=0.001); CCA 
IMT and WC (r=0.3; p=0.0001), SBP (r=0.3; p=0.0001),DBP 
(r=0.3; p=0.0001).  
Conclusions. PRA and CCA IMT increase in patients with AO 
accompanied by AH and atherosclerosis. 
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CONTROL OF CARDIOVASCULAR DISEASE RISK 
FACTORS AMONGST HYPERTENSIVE PATIENTS AT 
DIFFERENT CARDIOVASCULAR RISK OVER A 10 
YEAR PERIOD IN A PRIMARY CARE SETTING 
 
Yook Chin Chia 1 Siew Mooi Ching 2 
1Departmentof Primary Care Medicine, University of Malaya, 
Malaysia 
2Department of family medicine, University Putra Malaysia, 
Malaysia 
 
Objective: Patients with hypertension usually have more than one 
cardiovascular disease (CVD) risk factor placing them at medium 
to high risk for CVD events. Our study aims to examine the 
control rates of blood pressure (BP) glycaemia and lipids  among 
hypertensive patients of  different risk categories over a 10-year 
period 
 
Method: This is part of a randomly selected retrospective cohort 
study of  patients at a primary care clinic. Individual CVD risk 
was computed using the General  Framingham CVD risk score   
Patients were classified into low (<10% risk), medium (10%-
20%) and high risk  (>20%). Target BP was defined according to 
clinical practice guidelines Achievement of target  BP, glucose 
and lipid levels in 1998, 2002 and 2007 were captured.  
 
Results: 580 hypertensive subjects with  complete data were 
included in the analysis. Mean age  was 57.4(SD± 9.8)years; 
37.2% male. At baseline, 50(8.6%), 149(25.7%) and 381(65.7%) 
patients were in low, medium and high risk groups respectively. 
Target BP was seen in less than a third of the patients with high 
risk compared to higher control rates  of more than half in those 
with  low risk  at the end of 10 years follow-up.(Table 1) A similar 
pattern was seen with LDL-cholesterol control. 
 
Table 1 Control rates of CVD risk factors over 10-years  
 
Risk 
category 
Control rates (%) 
 BP Ldl-chol HBA1C* 
 1998 2007 
p 
value 
1998 2007 
P 
value 
1998 2007 p value 
Low 48 58.0 0.001 10 68.0 0.001 4.0 6.0 0.001 
Medium  22 53.7 0.007 9.4 59.1 0.001 4.7 15.4 0.007 
High  7.6 31.8 0.001 8.4 45.1 0.001 14.7 18.6 0.001 
*In only those with diabetes mellitus  
 
Conclusion: Although the overall control of BP, LDL and HbA1C 
improved over time in all risk categories, control in the high-risk 
group is far from optimal. Use of risk stratification to identify 
those at highest risk should be encouraged to improve 
management and hence reduce CVD events in those most at risk. 
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DIFFERENCES OF CAROTID INTIMA-MEDIA 
THICKNESS, PLAQUE SCORE AND PLAQUE AREA 
STENOSIS ACCORDING TO MULTIVESSEL DISEASE 
IN PATIENTS WITH ACUTE MYOCARDIAL 
INFARCTION 
 
Seung-Hwan Lee1, Sunyoung Park2, Jun-Won Lee1, Young-Jin 
Youn1, Sung-Gyun Ahn1, Byung-Su Yoo1, Junghan Yoon1 
 
1Yonsei University Wonju College of Medicine, 2Yonsei 
University Wonju College of Medicine, Wonju Christian Hospital 
 
Background: Carotid intima-media thickness (IMT) and plaques 
are used as surrogate markers of cardiovascular disease. But, it is 
still unclear whether carotid parameters play a role for stratifying 
established coronary artery disease (CAD). Therefore, we 
investigated the relationships between carotid parameters and 
extent of CAD in patients with acute myocardial infarction 
(AMI). 
Methods: Among 1351 patients received consecutively carotid 
ultrasound examination from Sep 2011 to May 2012, 137 patients 
diagnosed with AMI were enrolled (104 men and mean age 
64.9±12.7 years). IMT, plaque score (PS) and % plaque area 
stenosis (AS) were compared according to multivessel disease 
(>2 vessel disease). PS was computed according to the presence 
of plaque in 4 different locations of both carotid arteries. 
Results: There were no differences in baseline characteristics. But 
the higher proportion of non-ST-segment elevation myocardial 
infarction is observed in MVD group (54.9% vs. 30.4%, 
p=0.007). MVD group had higher incidence of plaques and SS 
(85.7% vs. 56.5%, p<0.001 and 20.7±9.5 vs. 12.2±7.9, p<0.001). 
Mean carotid IMT, PS and %AS were also higher in MVD group 
(0.84±0.21 vs. 0.76±0.15, p=0.033; 2.5±1.6 vs. 1.3±1.6, p<0.001; 
and 37.8±22.4% vs. 20.3±21.0%, p<0.001). PS was correlated 
with mean IMT, %AS values as well as SS and extent of coronary 
disease (r=0.415, p<0.001; r=0.770, p<0.001; r=0.189, p=0.027; 
and r=0.334, p<0.001). 
Conclusion: MVD in AMI patients was associated with increased 
CIMT, higher PS and %AS. PS showed significant correlation 
with the extent and severity of coronary artery disease in AMI 
patients. 
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EFFICACY OF NITRIC OXIDE IN STROKE - A 
PROSPECTIVE RANDOMISED CONTROLLED TRIAL 
IN ACUTE STROKE 
 
Philip Bath1, Cheryl Renton2, Sally Utton3 
1,2,3Division of Stroke, University of Nottingham, U.K.  
 
Rationale: Acute hypertension is associated with a poor outcome 
after stroke. No large trials have assessed the effect of altering BP 
during the acute phase of stroke on outcome. We are testing 
whether nitric oxide, a multimodal molecule given as glyceryl 
trinitrate (GTN), is safe and effective in improving outcome after 
acute stroke. Furthermore, around half of all patients admitted 
with acute stroke are taking antihypertensive therapy immediately 
prior to the stroke. No data exist as to whether it is beneficial or 
safe to stop or continue this treatment during the acute phase.  
Design: ENOS is a prospective, international, multicentre, 
randomised, parallel-group, blinded, controlled trial. 3,500 - 
5,000 ischaemic or haemorrhagic stroke patients with systolic BP 
140-220 mmHg, and within 48 hours of onset will be included. 
Subjects will be randomised to 7 days of single-blind treatment 
with transdermal GTN or control. Those patients taking prior 
antihypertensive therapy will also be randomised to continue or 
temporarily stop this for 7 days. ENOS is conducted over a secure 
internet site. The primary outcome is modified Rankin Scale at 90 
days which is carried out by a blinded assessor. The analysis will 
be by intention to treat. 
 
Trial status: As at 26th April, 2012, 2990 patients had been 
recruited from 155 centres (Australia, Canada, China, Denmark, 
Egypt, Georgia, Hong Kong, India, Italy, Malaysia, New Zealand, 
Philippines, Poland, Republic of Ireland, Romania, Singapore, 
Spain, Sri Lanka and UK). More centres welcome to join.  
 
Funding: The Medical Research Council. 
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COMPARISON OF CIRCADIAN BLOOD PRESSURE 
PATTERNS BETWEEN PATIENTS WITH TIA OR 
MINOR STROKE AND CONTROLS 
 
W. W. Zhang1,2, Dominique. A. Cadilhac1,6, Leonid Churilov1 , 
Geoffrey. A. Donnan2,4, Christopher. O’Callaghan2,5, H. M. 
Dewey1,2,3 
1National Stroke Research Institute, Florey Neuroscience 
Institutes, Victoria, Australia 
2Department of Medicine, University of Melbourne, Victoria, 
Australia 
3Neurology Department, Austin Hospital, Victoria, Australia 
4Florey Neuroscience Institutes, Victoria, Australia 
5Clinical Pharmacology, Austin Health, Victoria, Australia 
6Monash medical center, Victoria, Australia 
  
Background: The circadian rhythm in blood pressure (BP) is 
classified into different patterns, with dipper recognised as the 
normal pattern. Abnormal circadian blood pressure (BP) patterns 
have been found to commonly present in patients with stroke. The 
circadian BP pattern and the relationship with autonomic nervous 
function in patients with TIA or minor stroke is uncertain. 
Methods: Patients with TIA/minor stroke recruited within 7 days 
after onset and age-sex group matched control participants were 
assessed using a 24-hour ambulatory BP monitor (Spacelab 
90217) and an ECG-based Heart Rate Variability (HRV) test. The 
four BP patterns are dipper, non-dipper, reverse dipper and 
extreme dipper patterns.  
Results: 76 patients (mean age 68 years, 59% male) and 82 
controls (mean age 66 years, 54% male) were recruited. No 
statistically significant differences were found on the distribution 
of circadian BP patterns and the HRV variables comparing 
patients and controls. A greater proportion of subjects with a 
history of hypertension (n=79) had abnormal circadian BP 
patterns (risk difference -0.17, 95%CI -0.32 to -0.01, p=0.04) and 
lower HRV (p<0.05) than subjects without hypertension (n=61).  
Conclusion: Patients with TIA/minor stroke have similar HRV 
and circadian BP patterns when compared to controls. This differs 
from studies of acute stroke where impaired HRV and abnormal 
BP pattern are more likely to be present and treatment according 
to different circadian BP variations has been recommended. 
Further studies are needed to provide more information on the 
influence of autonomic nervous system and circadian BP patterns 
for TIA and minor stroke. 
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ARTERIAL WAVES AND RESERVOIRS IN 
HYPERTENSION 
 
AD Hughes, J Davies, KH Parker 
International Centre for Circulatory Health, Imperial College 
London, UK 
 
The shape of the blood pressure (BP) waveform has been used for 
diagnostic purposes in hypertension for over a century and is 
indicative of ventricular-arterial interactions arising from the 
functional and structural characteristics of the circulation.  The 
circulation is complex and a complete 3-dimensional description 
of its time-dependent behaviour is currently beyond computation, 
consequently simpler models have been used to understand the 
BP waveform and its relationship to cardiovascular function in 
hypertension. One of the simplest models of the circulation first 
proposed by Hales in 1733 [1] is the ‘Windkessel’ model where 
the arterial circulation is approximated by a compliant reservoir 
coupled to outflow via a resistance. This approach has been 
largely superseded by models that consider the BP waveform to 
be the product of additive forward and backward waves (due 
respectively to ventricular ejection and reflection of the ejection 
wave). This approach has been fruitful but is not without 
problems, notably that it predicts simultaneous ‘self-cancelling’ 
forward and backward waves in diastole. More recently we and 
others [reviewed in 2] have proposed a simple heuristic model 
(the wave-reservoir model) that combines elements of the 
Windkessel and wave models. This approach accords a role to 
large arterial compliance and the change in arterial volume over 
the cardiac cycle, (termed the reservoir) while also allowing a 
major role for wave reflections and re-reflections in shaping the 
morphology of the pressure and flow waveforms (excess 
pressure). While a simplification, this approach is supported by 
experimental evidence in humans and animals. Importantly, 
parameters derived from this model appear to have improved 
prognostic value over other measures of the BP waveform. In an 
analysis of the CAFE sub-study of the ASCOT trial the integral 
of excess pressure was a significant predictor of all cardiovascular 
events (hazard ratio [95% confidence interval] = 2.2 [1.5–
4.0],p<0.001) and was independent of age, sex, treatment, and 
conventional cardiovascular risk factors, including  brachial BP, 
central systolic BP, central pulse pressure, augmentation index 
and heart rate.  
 
1. Hales, S. Statistical Essays Containing Hemostatics , 
London, 1733. 
2. Tyberg et al. Med Biol Eng Comput. 2009;47:221-32. 
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MULTIPLE BIOMARKERS AND IMPROVEMENT IN 
THE PREDICTION OF CHD OUTCOME: ANGLO-
SCANDINAVIAN CARDIAC OUTCOME TRIAL (ASCOT) 
NESTED CASE-CONTROL STUDY 
 
Peter S Sever1, Choon L Chang1, Paul Welsh2,  Neil R Poulter1, 
Naveed Sattar2 
1International Centre for Circulatory Health, Imperial College 
London,UK, 2Institute of Cardiovascular and Medical Science, 
University of Glasgow,UK 
 
Background: The usefulness of contemporary biomarkers when 
added to a predictive model using traditional risk factors remains 
uncertain.  We compared the predictive value of 11 blood 
biomarkers:  markers of dyslipidaemia (total cholesterol, HDL-c, 
LDL-c, Apo A, Apo B); inflammation (C-reactive protein(CRP),  
Monocyte Chemotactic Protein-1(MCP),  Osteoprotogerin 
(OPG),  and Osteopontin(OPN)) ; cardiac and renal dysfunction 
(Nt-proBNP, cystatin C).  
 
Methods and Results: 273 incident CHD cases and 563 matched 
controls from ASCOT participants were included in analyses. Nt-
proBNP was the strongest independent risk factor in the 
conventional non-lipid model (OR 1.38 (1.15-1.65) per increment 
SD), followed by Apo B (OR of 1.26 (1.07-1.48)). The addition 
of Nt-proBNP improved the area under the Receiver Operating 
Characteristic curve (AUROC) (0.629 (0.587-0.672) vs 0.606 
(0.563-0.648), with continuous net reclassification improvement 
(NRI) of 20.2% (p=0.006). Model with Apo B was the second 
most predictive model (AUROC: 0.624, NRI 14.0%).  In a 
stepwise conditional logistic regression model that included 8 
newer biomarkers, Apo B, Nt-proBNP and OPG significantly 
related to CHD events (ORs 1.68 (1.25-2.25); p=0.001, 1.37 
(1.12-1.67); p=0.002 and 1.46 (1.07-2.01); p=0.02 respectively) 
and significantly increased AUROC (0.662 vs 0.611; p=0.01). 
This led to 55.7% of cases being reclassified to a higher and 
34.8% to lower continuous risk threshold. 
 
Conclusion:  Apo B and Nt-proBNP are stronger predictors of 
CHD risk than LDL-c in this  cohort.  Other biomarkers were 
significantly independent predictors of CHD but  incremental 
predictive value was modest.  The predictive power of  traditional 
risk factor models  may be strengthened by including Apo B, Nt-
proBNP and OPG. 
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CHANGES TO ANTIHYPERTENSIVE MEDICINES 
DURING HOSPITAL ADMISSION FOR THE ELDERLY  
 
Tariq Alhawassi1, 2, Beata Bajorek3,4, Lisa Pont1, 5 
1Faculty of Pharmacy, The University of Sydney, Australia, 
2Pharmacy College, King Saud University, Saudi Arabia, 3School 
of Pharmacy, University of Technology Sydney, Australia, 
4Department of Pharmacy and Clinical Pharmacology, Royal 
North Shore Hospital, Australia, 5Faculty of Nursing, The 
university of Sydney, Australia.  
 
Background and objectives: Understanding current patterns of 
antihypertensive utilization, especially among the elderly 
population, is essential for ensuring optimal clinical care. The aim 
of this study is to understand patterns of antihypertensive use and 
medication changes during hospitalisation in elderly hospitalized 
patients. Design and methods: A retrospective, cross-sectional 
medical records survey of medicine use and blood pressure 
control in 646 elderly (>65 years) patients (n=646) admitted to a 
large tertiary Australian teaching hospital during 2010 was 
conducted. Blood pressure control was assessed according to the 
current Australian guidelines1. Results: This study presents the 
results from the first 117 patients. Almost two thirds (62.4%) of 
patients had a documented history of hypertension. The mean age 
of the hypertensive patients was 81.3 years (range: 65.4-95.8) and 
66 % (n=48) were female. The most commonly prescribed 
antihypertensives on admission (23.7%) and on discharge 
(24.8%) were ACEIs. During hospitalisation 45% of patients 
experienced changes to their antihypertensive regimen despite the 
majority of patients (n=82.2%) being admitted for non-
cardiovascular related indications. Only one patient was admitted 
with for management of hypertension. Information on pre-
admission blood pressure control was unavailable for most 
patients (83.6%) and for the patients for whom BP on admission 
was known, 35.6% were considered to be at target. On discharge, 
63.9% of patients had a target BP reading. Conclusions: The 
hospitalised elderly represent a vulnerable population. Many 
patients experienced to changes to their antihypertensive 
regimens during hospitalisation despite a lack of long term 
information about blood pressure control. 
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HYPERTENSION: MOSTLY A PROBLEM OF 
AWARENESS OR ADHERENCE TO TREATMENT? 
 
Maurizio Destro1, Giuseppina Patrizia Dognini1, Francesca 
Cagnoni1, Dario Mori1, Alessandro Belotti Masserini1, Simone 
Panza1 
1General Medicine Unit, Treviglio-Caravaggio Hospital, A.O. 
Treviglio, p.le Ospedale 1, Treviglio 24047 (BG) Italy 
 
Background: Hypertension (HT) represents the most important 
cardiovascular (CV) risk factor, but the target blood pressure is 
not reached in the majority of hypertensive treated patients. Aim 
of this work was to evaluate a sample of population to assess: 1– 
prevalence of HT and of  treated “target patients”; 2- to compare 
these findings with those already available; 3- to evaluate the 
awareness that HT is a CV risk factor. 
 
Methods: 1098 subjects (mean age 58y, M=596, F=500, 
M/F:0.84) were evaluated. CV risk factors, HT management and 
comorbidities were collected and blood pressure (BP) was 
measured. 
 
Results: Among the 1098, 652 declared themselves 
"normotensive" and 446 "hypertensive". In 802/1098(73%), BP 
values were <140/90mmHg, while in 296(27%) were >140/90: 
among these last, 180/446(40%) belonged to the group of 
"hypertensive", thus representing "non-target patients”. No 
differences in terms of risk factors and medications were found 
when comparing "non-target patients” vs "target patients” (with 
the exception of coronary artery disease). An inverse relationship 
between number of drugs and pressure target was confirmed. 
Among "non-target patients”, 30(16%) were not treated and 
43(23%) did not remember the therapy. 
 
Conclusions: Our data are consistent with those reported in 
literature regarding HT prevalence in Italy. On the contrary, the 
rate of “target patients” resulted significantly higher compared to 
literature (60% vs 30-35%), as significantly higher resulted the 
number  (98/446, 22%) who did not remember the treatment. Our 
results suggest that the failure of BP control is related both with a 
poor therapy compliance and a weak awareness. 
 
 
 
Adjusted OR p value AUROC  (95% CI)
Basic Model 0.6056   (0.5634, 0.6478)
+ individual biomarkers
HDL 0.86 0.10 0.6107   (0.5686, 0.6527)
Apo A1 0.86 0.09 0.6109   (0.5689, 0.6528)
Log MCP 1.05 0.66 0.6093   (0.5668, 0.6519)
Log cystatin C 1.05 0.70 0.6064   (0.5643, 0.6485)
Log OPN 1.05 0.44 0.6093   (0.5673, 0.6513)
TC 1.05 0.55 0.6066   (0.5647, 0.6486)
Log OPG 1.09 0.42 0.6188   (0.5761, 0.6614)
LDL-c 1.20 0.04 0.6108   (0.5690, 0.6525)
log CRP 1.24 0.01 0.6210   (0.5797, 0.6623)
Apo B 1.26 0.005 0.6244   (0.5828, 0.6660)
log BNP 1.38 0.001 0.6291   (0.5868, 0.6715)
.5 1 1.5 2
               Odds ratio and 95% CI (log scale)
512 
IS IT A PROMISING MIRACLEOUS THERAPY? HIGH-
TONE EXTERNAL MUSCLE STIMULATION 
ELECTROTHERAPHY IN THE TREATMENTS OF 
RESISTANT AND IRREVERSIBLE SYMPTOMATIC 
PERIPHERIC POLYNEUROPATHY WITH DIABETES 
MELLITUS, CHRONIC KIDNEY DISEASE AND 
PRIMARY HYPERTENSIVES 
 
Y Sagliker1, N Paylar2, A Heidland3, A Keck3, R Erek4, P 
Kolasin5, P S Ozkaynak2,,H S Sagliker2  and I Gokcay1 
1Nephrology-Hypertension, Cukurova University, Adana, 
Turkey; 2Sagliker Hypertension Unit, Adana, Turkey; 
3Nephrology, Würzburg University, Würzburg, Germany; 
4Neurology, Özel Adana Hospital, Adana, Turkey and 5Duzen 
Laboratories, Adana, Turkey 
 
Introduction and Aims: Chronic resistant peripheral neuropathies 
are leading disturbances in DM, CKD and PH patients .It has been 
known for thousand years applications of electrical energy by 
religious genius or unique animals such as electric fish in bottom 
of oceans yoga,trancendental meditation ,biofeedback approaches 
are reasonably somewhat effective. Methods: 20 DM patients 
with peripheric neuropathies on lower limbs with severe 
tinglings,burnings,pains,numbness,sleeping disturbances,general 
or local sensing abnormalities ( 7 parameters ) ,20 CKD and 10 
PH patients with same symptoms included into study.Patients had 
severe medical treatments including 
analgesics,antidepressives,antianxietics,vit B complex , 
gabapentin like drug therapy,several types of phsical therapies 
recently.HMTE device, HiTop 181-H ( GBO Medizintechnik ) 
applied to groups as three times a week for one hour during one 
month. 
Before study and after treatments ,SBP,DBP,MAP,HR with 
Mobil-O-Graph NG automated continously BP recorder (APC 
Cardiovascular ) , EMG-ENG detections , HbA1c,albumin , CRP 
values , for sempathetic nervous system NE.E,Dopamin , 
PRA,aldosteron,AII levels determined.Results before and after 
compared acording to universal criteria.Decriments in phisical 
symptoms cathegorised in a scale as from 10 to 1 degree 
decrimentally or from 1 to 10 gradually. Results: All three 
cathogories faced miraculous decriments at least 2 or 3 scales in 
peripheral symptoms on lower limbs for 7 parameters.Working 
and walking capacities improved dramatically and psycosocial 
behaviours changed, felt themselves like never 
before.SBP,DBP,MAP,HR were significantly decreased as 
expected at least 20% (figure 1 and 2) .We expect hormonal 
values to be in accordance with dramatical clinical improvements 
as well. 
 
 
 
Conclusions: New treatment modality appears to have miraculous 
effects to be accepted officially and privately in state and private 
treatment centers.If we consider prevelances of 5 % for DM, 8% 
for CKD and at least 27% for PH in world presently we believe 
those patients have rights to be treated in reasonable fashion with 
this novel modality.This is a sine qua non humanitarian task. 
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POOR COMPLIANCE AND UNFAVORABLE 
CARDIOVASCULAR OUTCOME IN HYPERTENSIVE 
PATIENTS: AN IMPORTANT AND UNDERESTIMATED 
HEALTH ISSUE 
 
Marco Vatrano1, Roberto Ceravolo1, Cristina Nesta1, Vittorio 
Pascale1, Alessandro Ferraro1, Francesco Borrello1, Vincenzo 
Antonio Ciconte1 
1Haemodinamic and Interventional Cardiologic Unit, Pugliese-
Ciaccio”. Hospital 
 
Objective: Cardiovascular disease is characterized by significant 
prevalence and cost in the managed care setting. Despite 
overwhelming evidence in favor of periodic evaluation about own 
disease states, above all after prior cardiovascular event, patient’s 
attitude to these potential opportunity remains often suboptimal. 
We performed the study to establish the benefits of an adequate 
compliance to periodic cardiologic evaluation and the potential 
interventions to improve clinical outcomes. Design and Method: 
120 hypertensive patients (62 ± 13 years old) with ST-elevation 
myocardial infarction (STEMI) treated by primary percutaneous 
coronary intervention (PCI) were enrolled to a scheduled control 
visit (at 30 days and every 4 months) with appropriate 
instrumental exam, as it is stress test to evaluate residual ischemia 
(at 4 month and every years) and echocardiography to evaluate 
cardiac performance improvement (at 6 month and every years), 
and a periodic telephone contact with trained personal (Physician 
or nurse). The dataset of information was collected during the 
period between July 2005 and December 2008 and the statistical 
analysis was conducted by dividing the population in non-
compliance group (nc-Group) and in compliance group (c-
Group). Results: The primary outcome (death, reinfarction, re-
hospitalization or residual ischaemia) occurred in 28 patients 
(23.3%) in the nc-Group compared with 92 patients (76.4%) in 
the c-Group (odds ratio: 0.96; p=0.003) with event-free survival 
significantly higher in the last group (Log Rank test p=0.002). 
Conclusions: To overcome the issues surrounding the lack of 
patient’s compliance, our interventions was designed not only on 
the optimal medical strategy but also on successful patient and 
provider – focused behavioral strategies. Interventions for 
improving adherence to periodic follow-up will provide an 
opportunity to decrease morbidity, mortality, and hospitalization 
associated with cardiovascular disease. 
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ESTIMATION OF AORTIC FLOW VELOCITY FROM 
DERIVED AORTIC PRESSURE WAVEFORMS 
 
Audrey Adji1,2, Michael O’Rourke2,3, Alberto Avolio1, Thomas 
Weber4 
1Australian School of Advanced Medicine, Macquarie University, 
Sydney, NSW; 
2St Vincent’s Clinic, Sydney, NSW;  3University of New South 
Wales/ VCCRI, Sydney, NSW; 
4Klinikum Wels-Grieskirchen, Wels, Austria 
 
Background:  
Ascending aortic flow waveform can be generated from 
ascending aortic pressure if ascending aortic impedance can be 
gauged from age. 
 
Methods:  
Radial artery pressure waveforms (applanation tonometry) were 
transformed using generalised transfer function (GTF) to generate 
aortic pressure. Age-specific impedance transfer function (ITF) 
was then used to generate aortic flow. Data were obtained in 160 
male patients (age 33-80) undergoing cardiac catheterisation for 
suspected coronary disease. Doppler flow and applanation 
tonometry studies were undertaken within 1 hour.  
 
Results:  
Generated flow waves showed an early systolic peak which 
corresponded well to the initial pressure peak (106+8 msec after 
the wavefoot). Flow fell to near zero at the incisura and remained 
at this level through diastole. Late systolic flow was lower in the 
older than in the younger patients, with concavity in older persons 
corresponding to convexity of the pressure waveform. The 
Doppler flow wave was broad, representing different flow 
velocities. The peak of the inner envelope was approximately 
60% of the other envelope, when this could be clearly seen. Peak 
flow velocities were 102.5 (SEM 1.5) cm/s (Doppler, outer 
envelope), 62 cm/s (Doppler, inner envelope) and 55 (SEM 2) 
cm/s (GTF/ITF formula). 
 
Conclusions:  
Generated flow waves show aging changes which are not 
apparent in Doppler flow patterns; they are realistic in shape and 
explicable on the basis of LV weakening and variably increased 
early wave reflection. High peak flow calculated from Doppler 
waves may be due to the narrow outflow tract. MRI flow waves 
show lower values. 
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MEASUREMENT OF CENTRAL BLOOD PRESSURE 
USING SUPRA-SYSTOLIC BRACHIAL CUFF: A 
METHOD OF COMPARISON OF PULSECOR AND 
SPHYHMOCOR IN 1117 PATIENTS. 
 
Justin E Davies1, Chloe Park1, Therese Tillin1, Nish Chaturvedi 1, 
Alun Hughes 
1International Centre for Circulatory Health, Imperial College 
London  
 
Background: Estimated aortic (or central) systolic pressure 
(cSBP) differs from peripheral pressure and may be a better 
predictor of cardiovascular events. SphygmoCor® (AtCor, 
Sydney, Australia) uses applanation tonometery to derive cSBP 
by application of a generalised transfer function to radial pulse 
waveforms.  PulseCor® (PulseCor, Auckland, New Zealand) is a 
new device that estimates cSBP from suprasystolic brachial cuff 
waveforms. We compared blood pressures measured by both 
devices  
 
 
 
 
Methods: 1117 individuals (69.6±6yrs) underwent consecutive 
radial (SphygmoCor) and brachial (PulseCor) waveform 
measures. Method comparison was performed by Bland Altman 
analysis in Stata 12.0. 
  
Results: Measurements made by the two devices were similar 
(Table 1). cSBP estimated by PulseCor tended to be higher than 
SphygmoCor, although the difference was within the American 
Association for the Advancement of Medical Instrumentation 
(AAMI) standards (< 5mmHg and SDdiff was <8mmHg). Bland 
Altman analysis showed no systematic bias between devices 
across the range of blood pressures measured (Figure 1). 
 
Variable PulseCor SphygmoCor Difference LOA 
cSBP, 
mmHg 
136.3±15.1 133.1±15.8 3.2±4.4 -5.4, 
11.7 
cDBP, 
mmHg 
85.7±10.3 85.4±10.4 0.3±0.9 -1.5, 2.2 
 
Table 1. Close agreement in central haemodynamics between 
PulseCor and SphygmoCor 
 
DBP, diastolic blood pressure; SBP, systolic blood pressure; 
LOA, limits of agreement. Data are means (SD). 
  
Figure 1. Bland-Altman plot between Pulsecor and SphygmoCor 
 
Conclusions: PulseCor and Sphygmocor give similar estimates of 
central blood pressures. The slightly higher cSBP measured by 
PulseCor could relate to the use of brachial rather than radial 
pressure to calibrate SphygmoCor. 
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ACCURATE, NONINVASIVE, TRANSCUTANEOUS 
DOPPLER (USCOM) MEASURES OF CARDIAC OUTPUT 
AND VASCULAR RESISTANCE MAY IMPROVE 
GUIDANCE OF ANTIHYPERTENSIVE THERAPY 
 
Robert A. Phillips1,2, Malcolm J. West1, Chun-Ting Wang3, 
Darryl J. Burstow1, John F. Fraser1 
 
1The School of Medicine, The University of Queensland, 
Brisbane, Australia 
2Uscom Ltd, Sydney, Australia 
3ICU Department, Shandong Provincial Hospital, Shandong, 
China 
 
Background: Optimal control of hypertension remains 
challenging, suggesting protocols to guide antihypertensive 
therapies could be improved. Blood pressure (BP) level is used to 
define hypertension, and is a target for hypertensive management 
guidelines. However BP is the product of cardiac output (CO) and 
systemic vascular resistance (SVR), BP = CO x SVR. Therefore 
hypertension may be a consequence of high CO, high SVR, or 
both. Further, CO and SVR are the targets of anti-hypertensive 
therapy, with BP the measured variable. Consideration of 
hypertension as cardiogenic, raised CO, vasogenic, raised SVR or 
mixed types may improve guidance of therapy. Transcutaneous 
Doppler (USCOM, Uscom Ltd, Australia) provides simple, 
noninvasive and accurate measurements of CO with validation 
from 0.12l/min to 18.7l/min across many clinical applications 
including pre-eclampsia. The device is simple to operate and 
generates 22 parameters of cardiovascular performance 
instantaneously including Stroke Work and Cardiac Power. SVR 
is caculated from CO and BP. 
Case History: A 74yo female with severe uncontrolled 
hypertension (BP-187/85, mean BP=115mmHg, HR=104, 
SW=1886mJ) was treated with fluid control and glyceryl 
trinitrate 1.5ug/min/kg. USCOM examination demonstrated 
CO=12.3L/min and SVR=697Dyne.s.cm-5). The GTN and CRRT 
was ceased resulting and a further USCOM examination 
performed 30minutes later (BP-154/76, mean BP=102mmHg, 
HR=112, SW=1107mJ, CO=10.7L/min, SVR=866Dyne.s.cm-5) 
 
 Sys/Dia MAP SV SVI SVR SVRI CO CI HR SVV CPo SW 
Base 185/90 122 119 80 697 1040 12.3 8.2 104 23 3.2 1886 
Post Tx 154/76 102 99 67 866 1292 10.7 7.1 112 27 2.1 1107 
Day2 145/68 94 78 52 1007 1503 7.2 4.9 93 24 1.5 965 
Norm 116/65 82 66 40 1479 2486 4.8 2.8 72 <15 1.0 800 
 
Table 1. Haemodynamic variables monitored at baseline, 30 
minutes post cessation of treatment, and 16 hours later, compared 
to normal values. 
Conclusion: Simple noninvasive USCOM measurements of CO 
and SVR are feasible, and may improve our understanding of the 
pathophysiology of hypertension and guide more accurate and 
cost-effective delivery of individualised anti-hypertensive 
therapy. 
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HYPERTENSIVE MANAGEMENT GUIDELINES: HAS A 
FOCUS ON BLOOD PRESSURE MASKED THE 
IMPORTANCE OF CARDIAC OUTPUT AND VASCULAR 
RESISTANCE? 
 
Robert A. Phillips1,2, Malcolm J. West1, Joe Brierley3, Darryl J. 
Burstow1, John F. Fraser1Brendan E. Smith4 
 
1The School of Medicine, The University of Queensland, 
Brisbane, Australia. 
2Uscom Ltd, Sydney, Australia. 
3Paediatric and Neonatal Intensive Care Unit, Great Ormond 
Street Hospital for Children, London, England. 
4School of Biomedical Science, Charles Sturt University, 
Bathurst, Australia. 
 
Background: Control of hypertension can be difficult, suggesting 
current practices to guide antihypertensive therapies may be 
improved. Blood pressure (BP) is used to define hypertension, 
and is the target for hypertensive management guidelines. 
However BP is the product of the physiologic variables of cardiac 
output (CO) and systemic vascular resistance (SVR), BP = CO x 
SVR. Further the direct targets of interventional therapy are 
reduced CO and/or reduced SVR, and consequently reduced BP. 
However the relationship between CO and SVR is complex, 
compensatory and interdependent. The addition of accurate and 
noninvasively acquired CO and SVR targets to hypertensive 
management guidelines is physiologically rational and may 
improve the control of hypertension. 
Method: Six current hypertension management guidelines from 
the US, Europe, UK, Australia, Japan and Latin America were 
reviewed. The number of pages and words in each guideline were 
determined using the Microsoft Word Count function, and 
specific searches made for <CO>, cardiac output, <SVR>, 
vascular resistance, <BP> and blood pressure and the results 
tabulated.  
Results: In 446 pages of hypertensive guidelines from 6 different 
global organisations blood pressure was mentioned 3,131 times. 
Vascular resistance was mentioned 12 times, and cardiac output 
11 times. While BP target values were recommended in all 
guidelines, no CO or SVR targets were included in any of the 
guidelines. 
 
Source Pages Words CO Cardiac 
Ouput 
SVR Vascular 
Resistance 
BP Blood 
Pressure 
ACC 2011 76 69,251 0 6 0 5 346 220 
ESC+ESH 2007 75 78,312 0 3 0 1 76 821 
NICE 2011 36 7,155 0 0 0 0 0 101 
Aust 2010 39 13,281 0 0 0 0 136 19 
Japan 2008 189 105,263 0 2 0 6 3 1267 
Latin Am 2009 31 15,299 0 0 0 0 0 142 
Total 446 289,007 0 11 0 12 561 2570 
All 446 289,007 11 12 3131 
 
Table 1. Summary of content of six hypertension management 
guidelines and the frequency with which the physiologic variables 
associated with blood pressure are mentioned. 
 
Conclusion: Inclusion of CO and SVR targets in hypertension 
management guidelines is physiologically rational and may 
improve our understanding of hypertension and guide more 
accurate and cost-effective delivery of individualised anti-
hypertensive therapy. 
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NEW NONINVASIVE CENTRAL HAEMODYNAMIC 
NOMOGRAMS TO SIMPLIFY HYPERTENSIVE 
MANAGEMENT IN NEONATES, CHILDREN AND 
ADULTS 
 
Robert A. Phillips1,2, Malcolm J. West1, Brendan E. Smith3, Tim 
Rainer4, Joe Brierley5, Tim Harris6, Shao-ru He7, Darryl J. 
Burstow1, John F. Fraser1 
 
1The School of Medicine, The University of Queensland, 
Brisbane, Australia. 
2Uscom Ltd, Sydney, Australia. 
3School of Biomedical Science, Charles Sturt University, 
Bathurst, Australia. 
4Emergency Medicine Academic Unit, Chinese University of 
Hong Kong, Hong Kong. 
 
5Paediatric and Neonatal Intensive Care Unit, Great Ormond 
Street Hospital for Children, London, England. 
6Emergency Department, Royal London Hospital, London, 
England. 
7Department of Pediatric Cardiac Surgery, Guandong General 
Hospital, Guandong, China. 
 
Background: Control of hypertension can be difficult despite 
established blood pressure (BP) targets, widespread therapeutic 
guidelines and substantial public spending. As mean BP is the 
product of cardiac output (CO) and systemic vascular resistance 
(SVR), the underlying pathophysiologic cause of hypertension 
may be elevated CO, elevated SVR, or both. While 
antihypertensive therapies target the reduction of the primary 
variables CO and SVR, there are no recommended target values. 
The relationship between BP, CO and SVR is complicated by 
their interdependence and the autonomic regulation which 
preserves BP and perfusion pressure, but masking independent 
derangements of CO and SVR. Therapeutic protocols based on 
normalisation of accurate CO and SVR values may improve 
control of hypertension. 
As SVR and BP are instantaneous measures showing beat to beat 
variation, the use of stroke volume (SV) in place of CO, may be 
more appropriate. Further, as CO = SV x HR, and HR is 
modulated by baroreceptor effectors to preserve CO, SV may be 
a more sensitive measure of instantaneous cardiac performance. 
Both SV and SVR correlate with morphometry so the BSA 
indexed values of SVI and SVRI may provide logical central 
cardiovascular haemodynamic targets. 
USCOM (Uscom Ltd, Australia) measured SVI and SVRI, and 
contemporaneous oscillometric BP values were derived from 
3750 normal subjects ranging from neonates to 75yrs from 9 
global centres, and reference nomograms derived.  
Conclusion: These nomograms provide new normative targets for 
central haemodynamics and may guide more accurate and cost-
effective delivery of individualised anti-hypertensive therapy in 
neonates, children and adults. 
 
Age SV SVI SVR SVRI CO CI SW CPo MAP 
Neo 
4.2-6.8 
20.2-
30.4 
3679-
6457 
1204-
1606 
0.62-
0.94 
3.1-4.0 
17-57  
41-59 
5 37.4-
52.0 
47.9-
63.7 
1166-
1787 
11947-
1405 
3.18-
4.67 
4.1-5.7 
233-
578 
 
52-58 
10 56.2-
83.9 
48.4-
68.2 
949-
1541 
1116-
1867 
4.1-6.6 3.5-5.4 
354-
1068 
 
63-95 
12-16 79.4-
105.2 
53.3-
70.5 
740-
1242 
1102-
1850 
5.61-
8.15 
3.7-5.6 
432-
1262 
 
67-103 
26-35 
63-89 35-50 
848-
1583 
1454-
2767 
4.8-6.8 2.9-4.2 
779-
1069 
0.8-1.3 
89-99 
46-55 
63-81 36-51 
1084-
1587 
1712-
2766 
4.2-5.9 2.4-3.7 
680-
865 
0.8-1.1 
77-87 
>55 
55-71 35-46 
1205-
1646 
1876-
2565 
3.5-4.8 2.2-3.1 
509-
700 
0.5-0.8 
78-86 
 
Table 1. Normal haemodynamic and blood pressure values across 
neonates, children and adults from six expert centres (n=3750). 
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THE TIGHT HEART RATE CONTROL HAS NO ANY 
SIGNIFICANT INFLUENCE ON CENTRAL AORTIC 
PRESSURE IN PATIENTS WITH ISCHEMIC HEART 
DISEASE AND ARTERIAL HYPERTENSION 
 
Viktoria Popova1,2, Tamara Temirsultanova1,2, Yri Lopatin1,2 
1Volgograd State Medical University 
2Volgograd Regional Cardiology Center 
 
Background: The value of augmentation index (AIx)  is largely 
determined by the level of blood pressure (BP). However, the 
contribution of heart rate (HR) to aortic AIx remains unclear.  
Objective: to study the effects of HR lowering therapy on central 
aortic pulse pressure (CAPP) parameters in patients (pts) with 
ischemic heart disease (IHD) and controlled arterial hypertension 
(AH). 
Materials and methods: 15 pts with IHD and controlled AH (mean 
age 55.8±1.3 years), were enrolled in to this study and followed 
for 3 months.  The tight HR control was achieved by combine use 
of  beta-blockers and If inhibitor ivabradine. The CAPP values 
were measured by means of applanation tonometry using 
SphygmoCor device. 
Results: Parameters applanation tonometry at the beginning of the 
study were: aortic systolic BP (aSBP) 109,9 ± 1,6 mm Hg. HR 
68,7 ± 1,5 b/min. Aortic diastolic BP (aDBP) 76,1 ± 1,1 mm Hg. 
Pressure augmentation (AP) 9.2 [4.9, 13.6] mm Hg. AIx 21,8 
[14,2; 33,3%]. AIx @ HR75 26,2 [10,3; 33.1%]. Time of 
reflection (Tr) 136,7 ± 2,5 msec. Buckberg index (SEVR) 165,1 
± 4,4%. After 3 months of observation significant reduction of 
HR was noted (- 17,7% , p <0.01). Parameters of CAPP remained 
unchanged: aSBP 106,1 ± 1,2 mm Hg. aDBP 71,6 ± 1,3 mmHg. 
AP 7.4 [3, 8, 14] mm Hg. AIx 17,8 [11,2; 31,1%]. AIx @ HR75 
22,1 [9,2; 29,3%]. Tr 147,6 ± 3,9 milliseconds. Reducing SEVR 
8.3% (from 165,1 ± 4,4% to 181,9 ± 5,6%). 
Conclusions: HR lowering therapy has no significant effect on 
CAPP in pts with IHD and controlled AH. 
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EFFICACY AND TOLERABILITY OF FIMASARTAN, A 
NEW ANGIOTENSIN RECEPTOR BLOCKER, 
COMPARED WITH LOSARTAN (50/100MG): 12-WEEK, 
PHASE III, MULTICENTER, PROSPECTIVE, 
RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, 
DOSE ESCALATION CLINICAL TRIAL IN MILD TO 
MODERATE HYPERTENSION 
 
Sang Eun Lee, MD1, Hae-Young Lee,MD1, Han-Mo Yang, MD1, 
Hyun-Jai Cho, MD1 
Byung-Hee Oh, MD1 
1Department of Internal Medicine, Seoul National University 
College of Medicine, Seoul National University Hospital, Seoul 
 
Background: Fimasartan is a newly developed angiotensin 
receptor blockers (ARBs) that has not been compared with other 
ARBs. Objectives: We determined non-inferiority of fimasartan 
to losartan with regard to the efficacy and tolerability in patients 
with mild to moderate hypertension.  
 
Methods: This was a randomized, multicenter, double-blind, 
parallel group, dose-escalation, phase III, non-inferiority trial. 
Patients aged 18 to 70 years with mild to moderate hypertension 
were randomized to receive either fimasartan 60/120mg or 
losartan 50/100mg daily. The primary end point was non-
inferiority of improvement in mean siDBP for 12-week treatment. 
The incidence and severity of adverse drug reactions (ADRs) 
were evaluated to assess their tolerability. Results: 506 patients 
were randomly allocated to receive fimasartan (n=256) or 
losartan (n=250). There was no significant difference in baseline 
demographic characteristics between the two treatment groups. 
At week 12, siDBP was significantly decreased from baseline in 
both groups [-11.26±7.53 mmHg in the fimasartan group and -
8.56±7.72 mmHg in the losartan group (p<0.0001)]. The 
between-group difference was 2.70 mmHg (p=0.0002) and the 
lower limit of the two-sided 95% CI (1.27 mmHg) was higher 
than the pre-specified non-inferiority margin (-2.5 mmHg). The 
incidence of ADRs were 7.84% and 10.40% in the fimasartan and 
losartan groups, respectively (p-value=0.3181). Conclusions: The 
reduction of siDBP after 12 weeks of treatment with fimasartan 
60/120 mg was non-inferior to that of losartan 50/100mg. There 
was no significant difference in tolerability between the groups. 
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CORRELATION IN ACUTE CORONARY SYNDROMES 
BETWEEN ARTERIAL HYPERTENSION, OXIDATIVE 
STRESS, PLATELETS HYPERACTIVITY, 
ENDOTHELIAL DYSFUNCTION AND PROGNOSIS 
 
Elena Bobescu1,2, Alexandru Covaciu1, Dan Dobreanu1, Gabriela 
Ifteni1,2 
 
1Transilvania University of Brasov, Romania 
2Clinic County Emergency Hospital Brasov, Romania 
3University of Medicine and  Pharmacy Tg. Mures, Romania 
 
Aims: To evaluate in patients with non ST elevation acute 
coronary syndrome (ACS) the correlations between arterial  
hypertension, oxidative stress, platelets hyperactivity, endothelial 
dysfunction and prognosis  
Methods: 240 patients (pts), with ACS were divided in 2 groups: 
Group HTA (128 pts) with ACS and  arterial hypertension; Group 
non HTA (112 pts) with ACS without arterial hypertension. 
Biomarkers for platelets hyperactivity (ASPItest, ADPtest by 
Multiplate), endothelial dysfunction. (von Willebrand factor 
activity, flow mediated dilatation), oxidative stress (Total 
antioxidant status, Myeloperoxidase) and major acute 
cardiovascular events (MACE) were evaluated for 2 years of 
follow up. Statistic analysis: multiple regression, chi square test. 
Results: 
 
Group HTA 
Group non 
HTA 
p 
Total ACS patients - 240 128 (53.3%) 112(46.7%) ns 
Cardiovascular death 15(11.7%) 3(2.7%) 0.05 
Nonfatal AMI 21(16.4%) 6(5.4%) 0.025 
Stroke 10(9.4%) 2(1.8%) 0.05 
Ejection fraction < 40% 35(27.3%) 13(11.6%) 0.05 
Global wall motion score 
index (WMSI)  >1.7 
40(31.3%) 15(13.4%) 0.05 
ASPItest >30U 45(35.2%) 23(20.5%) 0.05 
ADPtest >50U 21(16.4%) 13(11.6%) ns 
Von Willebrand factor activity 
>169.7% 
31(24.2%) 13(11.6%) 0.05 
Flow mediated dilatation < 
4.5% 
38(29.7%) 15(13.4%) 0.05 
Total antioxidant status <1.3 
mmol/l 
35(27.3%) 13(11.6%) 0.025 
Myeloperoxidase MPO IgG 
ELISA > 20 U 
31(24.2%) 10(8.9%) 0.05 
 
Conclusions: In patients with ACS and HTA a significantly 
increased  incidence of: cardiovascular death, acute myocardial 
infarction, stroke, low left ventricle ejection fraction, high global 
wall motion score index, high oxidative stress, platelets 
hyperactivity and endothelial dysfunction were observed at 2 
years of follow up in comparison with group with ACS without 
HTA. 
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THE EFFECT OF VALSARTAN ON LEFT 
VENTRICULAR HYPERTROPHY AND BIOCHEMICAL 
MARKERS IN PATIENTS OF MILD TO MODERATE 
HYPERTENSION 
 
Kyung Tae Jung1, Soon Chang Park1, Shang Lee1, Woo Jeong 
Choi1, Won Ho Kim1, Ki Hoon Kang1. 
1Cardiovascular center, Eulji University Hospital, Republic of 
Korea 
 
Objective: The aim of the present study was to examine the 
effects of an angiotensin II receptor antagonist, valsartan, on 
echocardiographically proven left ventricular hypertrophy (LVH) 
and biochemical markers in patients with mild to moderate 
hypertension. 
 
Methods: 154 outpatients with hypertension were recruited at 
Eulji University Hospital. The left ventricular mass index (LVMI) 
was calculated by echocardiography. Hs-CRP, NT-proBNP, 
peripheral branchial pressure were measured in all patients 
included in this study. All of them were diagnosed mild to 
moderate hypertension. They were divided into 4 groups, 
according to receiving daily dose of valsaltan to control BP.  
 
Results: Dramatic decrease of systolic blood pressure, diastolic 
blood pressure of brachial artery were achieved in 4 groups. All 
subjects who entered the study, LVMI decreased significantly (p-
value < 0.001). After only 24 weeks of valsartan therapy, the 
mean LVMI decreased significantly, from 178.94±49.9 to 
167.62±45.58 g/m. Also, a significant decrease was observed 
after 24 weeks at 4 groups compared to baseline. There were no 
significant differences of biochemical markers in 4 groups 
compared to baseline. However, only NT-proBNP decreased 
significantly in valsartan + HCTZ (hydrochrolothiazide) group 
after 24 weeks ( P<0.05). 
 
Conclusions: In hypertension patients with LVH, treatment with 
valsartan, an angiotensin II receptor antagonist, reduced left 
ventricular mass. Also, this drug may be decreased biochemical 
markers in hypertension patients. The long-term risk-reduction 
effects will have to be evaluated in further trials. 
Key words: Hypertension; AngiotensinⅡreceptor blocker; Left 
Ventricular Hypertrophy ; CRP ; NT-proBNP 
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NON-DIPPER TYPE BLOOD PRESSURE VARIATION IN 
ADULT KAZAKHS ORIGINATES FROM THEIR 
CHILDHOOD 
 
Hiroshi Kawamura1, Yukio Ozawa1, Yoichi Izumi2, Yuji 
Kasamaki3, Masakatsu Ohta3, Tomohiro Nakayama4, Masumu 
Mahmut5, Zuhen Cheng5, Yitong Ma5 
1Blood Pressure Center, MJG Cardiovascular Institute, 
2Department of Cardiovascular Medicine, 3Departments of 
Cardiovascular Medicine, 4Laboratory Medicine, Nihon 
University School of Medicine, 5Department of Medicine, 
Xinjiang Medical University 
 
Objectives and Background: Many cases of non-dippers and 
hypertension have been documented amongst the elderly Kazakhs 
living in Xinjiang, China.  The purpose of this study was to 
discover whether or not such a large numbers in non-dippers still 
exist among young Kazakhs and to compare these to another 
similar aged minority, the Uygurs, living in the same region. 
 
Design and Methods: The total number of subjects were 280, 
dividing into four groups:  1.middle-aged Kazakhs (30-35 years 
old, n=93), 2.middle-aged Uygurs (30-35 years old, n=97), 
3.young Kazakhs (8-10 years old, n=42), 4. Young Uygurs (8-10 
years old, n=48).  We performed ambulatory blood pressure 
monitoring (ABPM) and defined non-dippers as having a 
nighttime systolic blood pressure (SBP) drop of < 10% compared 
to daytime SBP.  We analyzed SBP variation with the maximum 
entropy method (MEM). 
  
Results: Non-dippers in middle-aged Kazakhs were 52 %, 
whereas those in Uygurs were 18 %.  Those in young Kazakhs 
were 28 %, whereas those in Uygurs were 4 %.  Similarly to elder 
Kazakhs, middle-aged and young Kazaks still exhibited a greater 
percentage of non-dippers.  MEM analysis revealed that both 
middle-aged and young Kazakhs and Uygurs still exhibited the 
SBP variation having a frequency of 24-hr periodicity with high 
spectral density (PSD) and that of ultradian periodicity with low 
PSD.  PSD in young-aged Kazakhs did not differ from that in 
young Uygurs. 
 
Conclusions: 
The numbers of non-dippers in middle-aged and young Kazakhs 
were still larger than those in Uygurs. The circadian periodicity 
did not differ between Kazakhs and Uygurs. 
 
 
595 
CHANGING ECHOCARDIOGRAPHIC PARAMETERS 
AND CHARACTERISTICS OF THE DAILY BLOOD 
PRESSURE MONITORING IN POSTMENOPAUSAL 
WOMEN WITH METABOLIC SYNDROME 
 
Alexander Kopelev1,  Oksana Kislyak1, Antonina Starodubova1,  
Fatima Khautieva2 
1Russian Scientific Research Medical University Behalf Of NI 
Pirogov, 2City Polyclinic No. 178 
 
Objective:  
To study the connection of left ventricular hypertrophy with 
laboratory and instrumental characteristics of postmenopausal 
metabolic syndrome. 
 
Design and Methods:  
We conducted a history and physical examination, lipid profile, 
fasting glucose, glucose tolerance test, echocardiography, daily 
monitoring of blood pressure and compare them with those of our 
clinic in 2004-2005. Diet, the regularity of the recommended 
medications varied. 
 
Results:  
No significant changes in left ventricular mass index and its not 
there, but the number of women with left ventricular hypertrophy 
(31 vs 22). In patients with newly diagnosed left ventricular 
hypertrophy (n = 9), we found an increase in 5 years at an average 
body weight of 7 kg, increased waist circumference - 6 cm, 
marked increase in levels of total cholesterol, LDL, triglycerides, 
reduced HDL density and increase in blood glucose both fasting 
and oral glucose tolerance test. The essential dynamics of 
indicators of daily monitoring of blood pressure were observed 
by us. We also analyzed changes in left ventricular mass and its 
index, depending on the dynamics of body weight. When weight 
gain, these indicators were growing at maximum. This is 
consistent with our data on the most pronounced increase in body 
mass index and waist circumference in patients with first-time 
occurrence of left ventricular hypertrophy. 
 
Conclusion:  
The hypertrophy of the left ventricular myocardium occurs in 
postmenopausal women with weight gain, a significant increase 
in abdominal obesity, the deterioration of lipid and carbohydrate 
profile. Dynamics of blood pressure do not affect the 
development of left ventricular hypertrophy. 
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ATRIAL FIBRILLATION IS RELATED TO INFECTIONS 
IN ACUTE MYOCARDIAL INFARCTION 
 
Goran Koracevic1, Miodrag Damjanovic1, Miomir Randjelovic1, 
Dragan Lovic2,  Danijela Djordjevic-Radojkovic1, Marija 
Zdravkovic3, Aleksandar  Stojkovic1,  Maja Koracevic4 
1 Clinical Center, Department for Cardiovascular Diseases, Nis 
2 Clinic for Internal Medicine Intermedica, Nis 
3 University Hospital Medical Center Bezanijska kosa, Faculty of 
Medicine, University of Belgrade, Serbia  
4 University of Nis, Faculty of Pharmacy  
 
Background: Infections are common trigger of acute myocardial 
infarction (AMI) and inflammation is well-known contributing 
factor to atrial fibrillation (AF). The aim of this study is to analyze 
potential relation between AMI, AF and infection. There is no 
paper in PubMed aiming to investigate this inter-relation, out of 
28 search results with the terms „acute myocardial infarction atrial 
fibrillation infection“ on April 1st, 2012.  
 
Patients and Methods: 816 AMI patients were studied, 
hospitalized from 1998 to 2005, before (primary) PCI was 
available in our institution.  
 
Results: Infections were 3 times more prevalent among AF 
patients (20.59% vs 6.79%, p=0.000455). Mortality was also 
higher in patients with AF (13.21% vs 5.43%, p=0.0010). If AF 
was not converted to sinus rhythm, it was even better 
prognosticator of in-hospital death (p<0.0001). Moreover, heart 
rate was significantly higher in AF patients, increasing myocardial 
oxygen demand. Patients with AF were older (70.82 6.64 vs 62.18 
10.59, p<0.0001). Diabetes mellitus was more prevalent in AF 
group (49.06% vs 34.13%, p=0.0183) and plasma glucose level 
was higher (10.31 6.23 vs 8.44 4.97, p=0.0100). Left bundle 
branch block was more common in AF patients (p=0.0039). As 
expected, cigarette smoking was less prevalent in patients with 
AF.  
 
Conclusion: We demonstrated, for the first time, three times more 
prevalent infections in AMI patients with AF. It is plausible that 
this relation between infections and AF is causative. Since AF 
increases mortality in AMI, it is additionally important to prevent 
AF in AMI patients with infection. 
 
 
597 
IMPAIRED ENDOTHELIAL FUNCTION AND 
HYPOTENSION EPISODES IN PATIENTS WITH 
MODERATE-SEVERE HEART FAILURE  
 
Lyudmila Korostovtseva1, Ekaterina Moguchaya1, Ekaterina 
Kolesova1, Yurii Sviryaev1, Julia Sazonova1, Kirill Malikov1, 
Andrei Kozlenok1, Alexandra Konradi1  
1Almazov Federal Heart, Blood and Endocrinology Centre, St 
Petersburg, Russia  
 
Objectives and Background: Hypotension is associated with 
increased mortality in patients with heart failure (HF) [Lee T.T. 
et al., 2006]. It is unknown whether impaired endothelial function 
predisposes to hypotension episodes in this group. 
 
Design and Methods: Reactive hyperemia index [RHI, peripheral 
arterial tonometry (EndoPAT 2000, Israel)] and number of 
hypotensive episodes [blood pressure (BP) <100/60 mmHg 
daytime and <90/50 mmHg nighttime during non-invasive 24-h 
BP monitoring (GE Healthcare Tonoport, USA, 15-min daytime 
interval between BP measurements, and 30-min nighttime 
interval)] were measured in 17 stable HF patients with NYHA 
class III-IV. Hypotension index was defined as the ratio of the 
number of hypotensive episodes to the total number of successful 
BP measurements. 
 
Results: At least one episode of hypotension was present in 14 
(82.4%) patients. Hypotension indices for SBP and DBP were 
4.6% (0.0; 42.6) and 3.7% (0.6; 17.9), respectively. Lower RHI 
values, i.e. impaired endothelial function, were associated with 
increased systolic, but not diastolic hypotension episodes (r=-
0.78, p=0.01 and r=-0.21, p=0.53, respectively). There was a 
strong positive association between RHI values and EF (r=0.83, 
p=0.006).  Lower EF was also associated with hypotension 
episodes (r=-0.63, p=0.007 and r=-0.64, p=0.006 for SBP and 
DBP, respectively), and this association remained after 
adjustment for RHI (r=-0.65, p=0.04).  
 
Conclusions: Both impaired endothelial function (i.e. lower RHI) 
and systolic dysfunction (i.e. lower EF) seem to predispose 
to hypotension episodes in patients with moderate-severe HF. It 
is unknown whether strategies selectively improving endothelial 
function and/or cardiac contractility reduce the incidence of 
hypotension episodes in these patients. 
 
References:  
Lee T.T., Chen J., Cohen D.J., Tsao L. The association between 
blood pressure and mortality in patients with heart failure. Am 
Heart J. 2006;151(1):76-83. 
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ELDERLY HYPERTENSIVE PATIENTS: SILENT WHITE 
MATTER LESIONS, BLOOD PRESSURE VARIABILITY, 
BAROREFLEX IMPAIRMENT AND COGNITIVE 
DETERIORATION 
 
Daniel Cho2,  Agustín Grassi2, Virginia Gundel2, Ramiro 
Rodríguez2, Ramiro A. Sánchez1, Agustín J. Ramírez1 
1Sección Hipertensión Arterial y Unidad Metabólica, Hospital 
Universitario, Dr RG Favaloro y 2Facultad de Ciencias Médicas, 
Carrera de Medicina, Universidad DR RG Favaloro. 
 
Aims:  
To evaluatee the glycemic, and lipid profile and to state a 
relationship with body mass index (BMI) and genre, trying to 
identify a profile related to cardiovascular risk (CVR) in essential 
hypertensives (HT). 
 
Methods:  
We studied retrospectively 444 subjects classified as NT (ABPM 
day time <135/85 mmHg, n=94) or HT (ABPM day time ≥135/85 
mmHg, n=350), subdivided by genre and, according to their BMI, 
in normal weight (NW: 18.5-24.9 Kg/m2), overweight (OW: 25-
29.9Kg/m2) or Obese (Ob: 30-33.9Kg/m2). Fasting and 120min: 
glycemia (Gly b, Gly 120, mg%) and insulinemia (Ins b, Ins 120, 
U/ml), total cholesterol (Chol t), HDLc and LDLc fractions and 
triglicerides (TG; all in mg%) were measured. 
 
Results:  
NT females failed to show a specific metabolic profile. HT 
females showed a tendency to metabolic syndrome as BMI 
increase (Gly b NW: 87.1±4.3, OW: 98.4±5.01, Ob: 129.8±3.8, 
p<0.02; HDLc NW: 60.0±5.8, OW: 54.4±6.0, Ob: 52.5±4.9, 
p<0.05; TG NW: 104.5±11.1, OW: 148.7±12.6, Ob: 153.5±5.3, 
p<0.02). NT males behave as HT women. HT males, showed a 
tendency to increase Gly b (NW: 92.7±3.2, OW: 102.1±4, Ob: 
106.3±4.7, p<0.05), TG (NW: 144.8±9.7, OW: 146.4±5.9, Ob: 
206.5±11.5, p <0.05) with decrease in HDLc (NW: 48.0±2.3, 
OW: 46.3±1.4, Ob: 43.2±1.5, p<0.05). In HT males LDLc 
increase as BMI increased (NW: 111.6±5.5, OW: 129.7±4.4, Ob: 
137.6±5.0, p<0.05). 
 
Conclusions:  
A different tendency for metabolic syndrome is observed 
depending on genre and BMI either being the subjects NT or HT. 
This emphasizes the need to precociously determine the risk 
profile to start with the adequate treatment. 
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CORONARY IMPLANTATION OF SIROLIMUS-
ELUTING STENT IMPAIRS THE AORTIC 
COMPLIANCE IN PATIENT WITH CORONARY 
ARTERY DISEASE 
 
Marco Vatrano1, Roberto Ceravolo1, Cristina Nesta1, Vittorio 
Pascale1, Alessandro Ferraro1, Francesco Borrello1, Vincenzo 
Antonio Ciconte1 
1Haemodinamic and Interventional Cardiologic Unit, Pugliese-
Ciaccio”. Hospital 
 
Introduction. To the best of our knowledge, any studies evaluated 
potential influence on arterial stiffness, measured by pulse wave 
velocity (PWV), of percoutaneous coronary intervention (PCI) 
and stenting.  
Methods. 150 patients were enrolled and underwent coronary 
angiography. In 68 patients was performed coronary stenting 
(PCI group). PWV was invasively obtained before and after 
coronary stenting.  
Results. Coronary stenting produced a significant augment of 
PWV (from 4.59 to 5.82 m/s, P=0.000). In contrast, the sub-
population which performed angiography without PCI (noPCI 
group), didn’t show any significant change in PWV. The analysis 
of PCI group demonstrated that only implantation of Sirolimus 
eluting stent (SES) caused a significant increase of PWV (from 
4.62 to 6.15 m/s, P=0.029). In a stepwise multiple regression 
model stent length, glycaemia and body mass index were 
significantly associated with increase of PWV, accounting for a 
total of 51.7% of the variation (P=0.009). In particular, stent 
length accounted for 39.6% of the variance in PWV 
augmentation; glycaemia and body mass index explained an 
additional 12.1% of its variability. In the same analysis performed 
in PCI group, stent length accounted for 65.3% of the variance 
(P=0.024) and other than glycaemia and body mass index, also 
implantation of SES explained an additional 18.5%. 
Conclusion. We have shown, for the first time, a significant 
association between SES implantation and an central stiffness 
worsening. 
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URINE NUCLEAR MAGNETIC RESONANCE 
SPECTROSCOPY REVEALS DISTINCT PATTERNS OF 
MYOCARDIAL SUBSTRATE METABOLISM IN 
PATIENTS WITH CORONARY ARTERY DISEASE 
(UNSTABLE ANGINA PECTORIS) 
 
WANG Juan1, ZHAO Huihui1, LI Zhongfeng1, CHEN Jianxin1, 
XU Xuegong1, LUO Liangtao1, ZHANG Li1, WANG Wei1 
1Beijing University of Chinese Medicine, Beijing 100029, China 
 
Background:  
Coronary artery disease is the leading cause of morbidity and 
mortality in China, and unstable angina pectoris claims more than 
770 thousand lives every year. Based on the great potential of 
urinary metabolites,1H-NMR metabolic profiling technologies 
may offer the possibility of identifying novel biomarkers and 
pathways activated in unstable angina pectoris. 
Methods:  
Urine samples of 28 unstable angina pectoris patients and 23 
healthy people were analyzed by 1H-NMR spectroscopy in this 
study. Each spectroscopy divided into regions of 0.005ppm width 
(water region was excluded)was integrated. After processing the 
data, partial least squares discriminant analysis(PLS-DA) was 
performed using SIMCA-P+ software（v11.5,Umetrics, Sweden）
. 
Results:  
The score plot of PLS-DA showed good separation between case 
and control on the level of urinary metabolites. Several 
metabolites of unstable angina pectoris patients were altered 
,including the increased levels of proline, alanine, isoleucine 
,glucose, valine, histine, hippurate and the decreases levels of 
citrate, creatinine and taurine ,which still need more clinical 
studies to verify the results. Multiple biochemical changes 
indicated alteration of myocardial substrate use and energy 
dysfunction in patients with unstable angina pectoris. These 
findings added great value to urinary metabolites, also revealed 
potential biological mechanisms underlying unstable angina 
pectoris. 
Conclusion: 
The NMR-based metabolimics approach demonstrates good 
performance to identify urinary biomarkers and provides new 
insights into metabolic process related to unstable angina 
pectoris. 
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MEASUREMENT OF PERIPHERAL BLOOD 18-OXO-
CORTISOL LEVELS CAN DISCRIMINATE 
SURGICALLY CURABLE PRIMARY ALDOSTERONISM 
AMONG HYPERTENSIVE PATIENTS, OMITTING 
MANY STEPS OF DIAGNOSTIC WORKUP 
 
Fumitoshi Satoh1, Ryo Morimoto1, Masataka Kudo1, Yoshitsugu 
Iwakura1, 
Yoshikiyo Ono1, Ken Matsuda1, Kei Takase1, Kazumasa Seiji1, 
Hironobu Sasano1, Yasuhiro Nakamura1 and Sadayoshi Ito1 
1Tohoku University Hospital, Sendai, Japan 
 
Background: Primary aldosteronism (PA) is still underdiagnosed 
in general practice, because it is diagnosed and treated by the long 
steps, such as screening, confirmation testing and subtype 
diagnosis. Adrenal venous sampling (AVS) is most reliable 
subtype differentiating method, but it is costly, invasive and needs 
expert radiologists. 
Objectives: To determine the role of peripheral plasma levels of 
18-oxo-cortisol (18-oxo-F), which is a derivative of cortisol 
found in PA, in discriminating surgically curable aldosterone 
producing adenoma (APA) from essential hypertension (EH) or 
bilateral hyperaldosteronism (BHA). 
Design and Methods: Peripheral plasma levels of 18-oxo-F were 
measured in 79 EH patients and 237 PA patients by highly 
sensitive LC MS/MS. AVS lead the diagnosis of 121 BHA 
patients and 116 APA patients (including 29 patients with CT 
negative micro APA). APA was confirmed by clinical 
examinations after adrenalectomy and histological workup 
(including immunohistochemical analysis of steroidogenic 
enzymes). 
Results: Plasma aldosterone concentration (PAC), aldosterone 
renin activity ratio (ARR) and peripheral plasma 18-oxo-F in 
APA patients were significantly higher than those in EH or BHA 
ones. ROC curve analysis in diagnosis of APA versus EH or BHA 
demonstrated that an area under the curve was higher in the order 
of 18-oxo-F, PAC and ARR. Especially, CT-positive APA (87 
cases) can be diagnosed by peripheral plasma 18-oxo-F levels 
over 4.8 ng/dl, with sensitivity of 0.8 and specificity of 0.97. 
Conclusions: By measurement of peripheral blood 18-oxoF 
levels, APA can be discriminated from EH and BHA which 
should be medicated, omitting many steps of diagnostic workup. 
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HYPERTENSION AND DIABETES IN AFRICAN 
FAMILIES SHARING THE SAME GRANDFATHER: A 
CASE REPORT 
 
Donatien Mavoungou1, Brice Ongali1 
1Centre de Recherche sur les Pathologies Hormonales (CRPH), 
Université Omar Bongo,  
BP 12134, Libreville, Gabon 
 
Introduction: Growth seems to share several genes with 
cardiovascular diseases such as hypertension and diabetes. In 
animal models, salt susceptibility required full expression of 
testosterone by genes located on chromosomes Y, but 
chromosome X did not affect blood pressure (BP). Accordingly, 
testosterone is needed for full expression of salt-induced 
hypertension in male salt sensitive rats. Likewise, Fat distribution 
genes found on chromosome X P21-22 provide spontaneous 
mutation located on chromosome X dominant while mutations on 
Y chromosome offer males offspring’s possibility to be less 
affected by the disease.  
Purpose of the study: To verify the incidence of hypertension and 
diabetes in descendents from 5 families having the same 
grandfather and different grandmother. 
Results: Family 1 (FI): 3 girls and 2 boys. One of the boy 
developed stroke at adulthood. FII: 1 boy developed hypertension 
and stroke.  FIII: 1 girl who became hypertensive associated to 
diabetes. FIV: 1 boy and 1 girl who were hypertensive and 
diabetics. FV: 3 girls and 2 boys. One of the girls was 
hypertensive and diabetic with the younger son aged 27 treated 
for diabetes today. The sex ratios male and female were 2:1 for 
hypertension, 1:1 for diabetes. 
Conclusion: Chomosomes X and Y are involved in transmission 
of diabetese and hypertension,via related genes. 
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PREVALENCE OF METABOLIC SYNDROME AND RISK 
OF CARDIOVASCULAR DISEASE IN IMPAIRED 
GLUCOSE TOLERANCE SUBJECTS 
 
Muhammad Imran 
Z.A School of Medical Technology, Sindh Institute of Urology and 
Transplantation (SIUT), Karachi, Pakistan 
 
Metabolic Syndrome is the aggregation of conditions that 
together increases the risk of cardiovascular disease and diabetes 
mellitus in both normal glucose tolerance (NGT) and impaired 
glucose tolerance (IGT) subjects. It is estimated that around 20 to 
25 per cent of the world's adult population have the metabolic 
syndrome. Over the last 20 years the prevalence of metabolic 
syndrome has steadily increased in all populations, and making it 
one of the major global public health challenge. The objective of 
this study is to estimate the prevalence of metabolic syndrome 
and cardiovascular risk factors in impaired glucose tolerance 
(IGT) subjects. 
 
204 Impaired glucose tolerance and 30 normal glucose tolerance 
subjects of both genders were selected for the present study 
according to the American Diabetes Association ADA criteria, on 
the base of two hour glucose tolerance test. Anthropometric 
characteristics like Waist circumference, BMI, systolic blood 
pressure, and diastolic blood pressure were measured with 
standard techniques. Biochemical parameters like fasting blood 
sugar, fasting insulin, cholesterol, triglycerides, HDL-C, and 
LDL-C were determined by standard techniques, the HOMA-IR 
values were calculated with the help of formula. 
 
It is concluded from the present study that the prevalence of 
metabolic syndrome is significantly increased according to 
AACE, ATPIII definition criteria’s in impaired glucose tolerance 
subject, the study emphasizes strongly that MS is major factor to 
enhance the incidence of type2 diabetes and cardiovascular 
diseases in impaired glucose tolerance subjects. It is suggested 
that preventive measures and treatment can reduce the incidence 
of CVD and type2 diabetes in our population. 
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PREVALENCE, AWARENESS AND CONTROL OF 
ARTRIAL HYPERTENSION AND CARDIOVASCULAR  
RISK FACTORS  IN  BULGARIA 
 
Snezana Tisheva1, Svetla Torbova2, Stefan Naydenov3, Svetlin 
Tsonev3, Yoto Yotov4 
1Medical University- Pleven 
2Hypertension Exellence Center    
3Medical University- Sofia 
4Medical University-Varna 
 
Objective: Assessment of the recent prevalence, awareness and 
control of the arterial hypertension (AH) and concomitant risk 
factors (RF) in Bulgarian population.   
Design and method: A cross-sectional study, devoted to the 
World Hypertension Day 2011y., organized by the Bulgarian 
Hypertension League.  Included 1831 persons from 58 different 
cities, towns and villages– 764 males and 1067 females, mean age 
54,3±18,1 (19-83) years. Information about awareness and 
presence of AH and cardiovascular risk factors was gathered. 
Blood pressure (BP), blood sugar (BS), waist circumference was 
measured (WC), body-mass index (BMI) calculated.  
Results: The prevalence of AH in different age groups for man 
(m) and woman (  w) was detected. About 1033 persons (76.4%) 
– 499 males (72.2%) and 800 females (79.1%), p<0.001 were 
informed of the threshold values of BP. AH treatment: RAAS 
blockers 72.8%, Diuretics 56.3%, CaC blockers 32.4%, single pill 
combination 32%.With controlled hypertension were  351  
hypertensives  (57.4%) (no gender difference).  With newly 
detected hypertension- 398 (24.8%). 383 (26.8%) knew their WC 
– 129 (22.9%) males and 248 (29.8%) females (p<0.05); 74 
(7.3%) knew their BMI.  Increased WC was found in 1073 
(58.6%), 54.3% females vs. males 45.8%, (p<0.05). BMI >25 was 
found in 1054 (57.6%). Diabetes mellitus was present in 177 
(10.0%). Dyslipidemia was present in 438 (25.2%) – 154 (22.5%) 
and 269 (26.5%) of females, p<0.05. 
Conclusions:  The prevalence of AH and cardiovascular risk 
factors in Bulgarian population is high. The awareness about AH 
is relatively high, but the control of BP in the established 
hypertensives is not satisfactory. 
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PREDICTORS OF FUTURE THREE 
ANTIHYPERTENSIVE MEDICATION USE IN PATIENTS 
WITH ELEVATED BLOOD PRESSURE 
 
Yook Chin Chia1, SiewMooi Ching2 
1Departmentof Primary Care Medicine, University of Malaya, 
Malaysia, Affliation: Curtin University, Australia 
 2Department of family medicine, University Putra Malaysia, 
Malaysia 
 
Objectives: Many hypertensive patients require two or more anti-
hypertensive agents to achieve target BP. Factors that predict the 
need for three antihypertensive agents are not well identified. This 
study examines the predictors of  three antihypertensive drug use 
in a hypertensive population over a 10-year period.  
 
Methods: This is part of  a 10-year retrospective cohort study of 
1547 randomly selected adult patients registered at  a primary care 
clinic. Patients with hypertension in this cohort were selected for 
this analysis.  Demographic data, BP and anti-hypertensive drug 
use in 1998, 2002 and 2007 were captured from patient records. 
BP control was defined as <140/90 mmHg in those with 
hypertension alone  and <130/80 mmHg in hypertensives with 
diabetes  
 
Results: 886 patients with hypertension were included. Mean age 
was 56.5(SD±10.0) years. 35% were male. BP in 1998 and 2007 
was 146.0/87.8mmHg and136/79.5mmHg respectively. BP 
control at baseline was 15.4% and 37.4% in 2007 
At baseline 13(1.5%) patients were on 3 antihypertensive 
medication. At the end of 10 years, use of 3 agents increased to 
222 (25.1%)   
Logistic regression was performed. The independent predictors at 
baseline of future 3 antihypertensive medication use was SBP 
(OR 1.022, 95% CI 1.013-1.031) and weight(OR1.019, 95% CI 
1.007-1.032). 
 
Conclusion: Use of 3 antihypertensive agents over a 10-year 
period is low. This is reflected by the poor level of target BP 
achieved. Higher SBP and heavier weight were factors that 
predict the need for many agents. This suggests that many patients 
will need 3 drugs or more to achieve target BP. 
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DIFFERENCES IN CHOICE OF THERAPY FOR 
HYPERTENSION IN PATIENTS WITH CORONARY 
HEART DISEASE AND IN HIGH RISK INDIVIDUALS 
 
Borislav Georgiev1, Nina Gotcheva1, Vera Baytcheva1, Elina 
Trendafilova1, Dobromir Gotchev1 
1National Heart Hospital, Sofia, Bulgaria 2Military Medical 
Academy, Sofia, Bulgaria  
 
The Aim: This study was to analyse the choice of therapy for 
hypertension in Bulgaria. 
 
Materials: We have conducted two descriptive, cross-sectional, 
epidemiological studies: BULPRAKT-HEART-study 
(BULgarian PRospective Analysis of the physicians' Knowledge 
and Therapy choice in HEART Disease Treatment And 
Prophylaxis) and  EUROASPIRE (European Action on 
Secondary and Primary Prevention by Intervention to Reduce 
Events) III.  
 
Results: 63% of Bulgarian general practitioners (GPs) preferred 
to use ACE-inhibitors in monotherapy, 10%- diuretics, 12%- 
beta-blockers, 7%- calcium channel blockers (CCBs). 79% 
preferred for combination therapy ACE-inhibitors, 53%- 
diuretics, 34%- beta-blockers, 20%- CCBs. In patients with 
coronary heart disease (CHD), beta-blockers were used in 82%, 
ACE-inhibitors- in 62%, CCBs - in 22%, diuretics- in 43%. In 
high risk patients beta-blockers were used in 27%, ACE-
inhibitors in 63%, CCBs- in 26%, diuretics- in 28%. ACE-
inhibitors were equally preferred and used in hypertension 
treatment. The preference for CCBs and diuretics in combination 
therapy is nearly equal to the prescription rate. Beta-blockers are 
used almost as preferred for the treatment of high risk individuals, 
but much more than their preferences in case of hypertension in 
CHD patients. Only concerning beta-blockers GPs sharply 
differentiated between preferences and application according to 
the presence of CHD. This is not observed for CCBs use.  
 
Conclusions: Bulgarian GPs prefer and use CCBs and diuretics in 
combination therapy; they prescribe considerably ACE-inhibitors 
for mono and combination therapy. Beta-blockers are less used in 
the treatment of isolated hypertension and lots of hypertensive 
patients with CHD are treated by beta-blockers.  
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REDUCTION OF BETA-BLOCKER PRESCRIPTION 
WITH EVALUATION OF OVERALL 
CARDIOVASCULAR RISK IN HYPERTENSIVE 
PATIENTS 
 
Hae-Young Lee1, Myung-Cahn Cho2, Byung-Soo Yoo3, Mi-
Seung Shin4, Sung-Jee Park5, Sung-Woo Han6, Dong-Ju Choi7 
1Seoul National University Hospital   
2Chung-Buk University Hospital 
3Wonju college of medicine, Yonsei University 
4Gachun Gil Hospital  
5Samsung Hospital 
6Guro Hospital Korea University 
7Bundang Seoul National University Hospital 
 
Background and Objective: Optimal treatment of hypertension 
targets overall cardiovascular (CV) risk control beyond blood 
pressure control alone. The impact of the regular assessment of 
CV risk was evaluated. 
Methods: General physicians in the primary clinics and 
cardiologists in the tertiary hospitals were asked to collect data 
for at least five sequentially recruited patients with newly 
diagnosed mild-to-moderate hypertension. The pattern of CV risk 
management (each CV risk factor separately, personal bimodal 
classification as high/low risk, or use of the official CV risk 
assessment tool) was assessed. Change of CV risk was compared 
according to presence/absence of subsequent assessment. 
Results: 1) 1171 patients cared by 23 cardiologists and 1057 
patients cared by193 general physicians were assessed. 2) 
General physicians tend to care each CV risk factor separately 
(49% vs 39%) whereas cardiologists tend to care the hypertensive 
patients according to official CV risk assessment tool (13% vs 
5%). Interestingly, more general physicians (81%) responded to 
assess the CV risk regularly than cardiologists (30%) did. 3) 
Irrespective of regular assessment of CV risk, blood pressure was 
similarly controlled. However, high density lipoprotein, and 
triglyceride levels were significantly lower following regular 
assessment of CV risk with wider prescription of additional 
dyslipidemia medication including fibrate, niacin and bile acid 
resin.4) Interestingly, the prescription of beta-blockers was 
significantly lower in patients who were evaluated their CV risk 
regularly.  
Conclusion: With regular CV risk evaluation, residual CV risk 
was better controlled. Beta-blocker prescription rate might be 
reduced following subsequent CV risk evaluation during follow 
up. 
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THE ASSOCIATION BETWEEN FASING LIPID LEVELS 
AND THE RISK OF INCIDENT VASCULAR, AND ALL-
CAUSE MORTALITY: THE TAIPEI ELDERLY HEALTH 
EXAMINATION COHORT STUDY 
 
Wen-Liang Liu1, Yi-Ping Lin1, Chiang, Shuo-Ju2, Liang-Hao 
Hsu2, Tai-Yin Wu3, Mei-Ru Chen4   
1Institute of Clinical Research and Training, Taipei City 
Hospital,2Department of Internal Medicine ,Taipei City Hospital, 
Zhongxiao Branch,3Department of Family Medicine, Taipei City 
Hospital, Renai Branch, 4Department of Community Health, 
Taipei City Hospital 
 
Objective:  
To evaluate the association between fasting lipid levels and 
vascular cause-specific and all-cause mortality in a prospective 
cohort study. 
Methods: From 2001 to 2008, 115329 Taipei City elderly (aged 
over 65) citizens received free Physical Health Examination 
(PHE) at hospitals in Taipei. The PHE included medical history, 
physical examination and routine blood, urine and stool 
laboratory evaluation. Fasting lipid measures included total 
cholesterol (TC), triglyceride (TG) and high-density lipoprotein 
cholesterol (HDL-C).  The cause of death was retrieved from the 
National Registry of Mortality.  We used hazard ratio (HR) from 
Cox proportional hazard model with repeat measures to assess 
mortality risk for Lipid levels, while controlling for potential 
confounding factors (sex, age, pulse, disease history, BMI and 
velocity of weight change). 
 
Results:  
A total of 7367 deaths occurred between 2003-2008.  During an 
average 4.7-year follow-up, 1729 subjects had vascular-related 
deaths (946 cardiovascular disease, 636 cerebrovascular disease, 
and 147 hypertensive disease), while only . All three lipids 
measures were significantly associated with an decreased risk of 
all-cause mortality, while only TC and HDL-C were associated 
with an decreased HR of vascular-related deaths.  Among cause-
specific mortality, HDL-C were significantly associated with an 
lower risk of hypertensive mortality (HR=0.57, 95% CI:0.37-
0.88), cerebrovascular disease (HR=0.60, 95% CI:0.47-0.76)  and 
cardiovascular disease (HR=0.68; 95% CI:0.56-0.83). However, 
TC was not associated with hypertensive mortality (HR=1.31; 
85% CI:0.68-1.98). 
 
Conclusion:  
In the Taipei Elderly Health Examination Cohort Study, TG was 
weekly associated with vascular mortality. The association 
between high LDL-C and low mortality risk ( vascular-specific 
and all-cause) was nonetheless strong and consistent. 
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DUAL AND TIME-DEPENDENT EFFECT OF L-NAME 
TREATMENT ON THE CARDIOVASCULAR AND 
CENTRAL NERVOUS SYSTEMS 
 
Olga Pechanova, Stanislava Vrankova, Lydia Jendekova 
Institute of Normal and Pathological Physiology and Centre of 
Excellence for Nitric Oxide Research, Slovak Academy of 
Sciences, Bratislava, Slovak Republic  
 
Objectives: We aimed to analyze the time course effect of NG-
nitro-L-arginine methyl ester (L-NAME) on nitric oxide synthase 
(NOS) particular isoforms, NF-κB (p50, p65) and I-κB 
expressions, total NOS activity and blood pressure (BP) in rats. 
Design: 12-week-old male Wistar rats were treated with L-
NAME (40 mg/kg/day) for four or seven weeks. Results: Both 4- 
and 7-week-L-NAME treatments increased BP, however, NOS 
activity decreased in all tissues investigated after 4-week-L-
NAME treatment only. Interestingly, prolongation of the 
treatment to 7 weeks increased NOS activity in the aorta and 
heart, while decreased it in the brainstem, cerebellum and brain 
cortex highly significantly.  Endothelial NOS expression in the 
aorta and heart increased after 4-week-L-NAME treatment, and 
this increase was amplified after 7 weeks. On the other hand, 
eNOS in the above brain regions remained unchanged after 4-
week-L-NAME treatment and prolongation led to significant 
decrease of eNOS expression in these tissues. Neither nNOS nor 
iNOS changed during the treatments. NF-κB (p65) expression 
increased in both cardiovascular and brain tissues after 4-week 
treatment. Prolonged treatment decreased it in the aorta and heart.  
Conclusions: Increased expression of eNOS may be responsible 
for increased NOS activity in the cardiovascular system after 7-
week-L-NAME treatment. Decreased expression of eNOS led, 
however, to the highly significant decrease of NOS activity in 
brain regions. NF-κB (p65) protein expression seems to be 
responsible for eNOS expression regulation. Since BP increase 
persisted after 7-week-L-NAME treatment, we hypothesize that 
central regulation of BP is predominant in this form of 
hypertension. Supported by APVV-0742-10, VEGA-2/0190/11. 
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TRANSCATHETER RENAL DENERVATION: SAFETY 
AND EFFICACY FOR BLOOD FLOW OF KIDNEY FOR 
PATIENTS WITH HYPERTENSION 
 
T. Ripp1, S. Pekarskiy1, V. Mordovin1, T. Ryabova1 , V. 
Lichikaky1. M. Zlobina1, A. Krylov1, S. Popov1, R. Karpov1 
1Institute of Cardiology, Tomsk, Russia 
 
Objective.  
We studied the renal blood flow with a significant reduction in 
blood pressure after sympathetic denervation of the RF arteries. 
Methods.  
Study was initiated in essentially hypertensive patients with 
BP>160/100mm Hg despite three or more antihypertensive drugs. 
All participants of research have given the informed agreement. 
Primary efficacy endpoints: changes in BP, secondary – changes 
in renal blood flow(ultrasound dopplerography velosity (V) and 
resistive index (RI)) at 1weeks and 6months after RSD. 
Transcatheter RSD was done bilaterally using transfemoral 
access(4-8 ablation points, target t=50C, power limit=8watt, 
duration=2 min). The patients were instructed to maintain 
pharmacotherapy unchanged during the study. 
Results.  
TRD was performed in 35patients (aged 52±10 years). Two 
treated patients refused to continue in the study, 2 patient moved 
and was lost to follow-up. Of remaining 29 patients 18 reached 6 
month of follow-up. One case immediate damage of kidney was 
detected by intraoperational control angiography.3 patients had 
protein concentration in morning urine Initially=0.36g/l, after 
RSD 1w=0-0.29g/l. We have not found significant decrease in 
glomerular filtration. Only 1 patient had change in serum 
creatinine Initially=106mcmol/l, at 1w RSD=137mcmol/l. No 
significant changes: in renal blood flow were found 
initially/during1st week/at 6 months of follow-up: Vtrunc 
79,4±25,8/79,5±24,9/75,7±17,9cm/s p=0,97/0,33; Vsegm. 
44,7±12,4/43,2±10,3/40,2±10,2 cm/s p=0,36/0,71. But the RI in 
the segmental arteries was significantly decreased after RSD 
0,62±0,05/0,58±0,06/0,59±0,06 p=0,003/0,026. 
Conclusion.  
This study showed that renal endovascular RSD not damage 
blood flow and function of the  kidnay in patients with resistant 
hypertension. TRD also reduced peripheral vascular resistance 
after the procedure. 
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ACID-BASE BALANCE OF RENAL VENOUS BLOOD IN 
PATIENTS WITH SECONDARY HYPERTENSION  
 
Vladimir Voitovitch1, Rikhil Patel2,  
1Belarussian Centre of Transplantation Organs and Tissues, 9th 
City Hospital, Minsk, Belarus 2Exeter College, University of 
Oxford, Oxford, UK  
 
Background and Aims  
Accessing the literature did not reveal any data regarding the state 
of Acid-Base Balance (ABB) in Renal Venous Blood (RVB). 
During study of differential diagnostic arterial hypertension, 
plasma renin activity and other renal hormones we 
simultaneously investigated ABB of RVB in patients with 
secondary hypertension. The aim of this study was to explore the 
level of renal ischemia in patients with different lesions of the 
kidney and renal artery accompanied with arterial hypertension 
by determination of ABB in RVB. 
 
Methods   
44 patients with different kinds of renal artery (RAL) and small 
kidney lesions (SKL) and 18 with polycystic kidney disease 
(PKD) have been studied by measuring pO2, SO2%, pCO2, pH, 
BE, BB, HCO3, TCO2 in abdominal aortas and RVB.  
 
Results:  
Abdominal aortas-
pO2:97.7±3.9;SO2%:97.2±3.5;pCO2:34.97±1.78 
RVB of RAL - pO2:62.5±4.3;SO2%:90.1±1.8;pCO2:35.11± 0.96  
RVB of RAL (opposite side) - 
pO2:65.0±3.4;SO2%:91.2±0.95;pCO2:34.95±0.72    
RVB of SKL - pO2:70.4±4.9;SO2%:91.8±0.8;pCO2:39.2±1.99 
RVB of SKL (opposite side) - 
pO2:81.6±6.4;SO2%:95.0±1.3;pCO2:34.95±0.72 
RVB of PKD (right side) - 
pO2:57.9±2.8;SO2%:89.2±2.5;pCO2:33.7 ±1.51 
RVB of PKD (left side) - 
pO2:59.4±3.8;SO2%:90.2±1.9;pCO2:32.63±1.71 
 
Conclusions  
The obtained results have shown that the essential data in ABB in 
RVB in patients with secondary hypertension is very stable and 
there is a statistically non-significant difference between lesion 
and opposite side RVB in RAL and SKL. Furthermore, only in 
patients with PKD are levels of pO2 and pCO2 in RVB statistically 
lower than other groups. The remaining data of ABB in patients 
with secondary hypertension is statistically no different to normal 
levels and confirms stable ABB in RVB even in patients with 
PKD. 
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DUAL ROLE OF KIDNEYS IN BLOOD PRESSURE 
REGULATION IN PATIENTS WITH AUTOSOMAL 
DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) 
 
Vladimir Voitovitch1 
1Belarusian Centre of Transplantation Organs and Tissues, 9th 
City Hospital, Minsk, Belarus 2Exeter College, University of 
Oxford, Oxford, UK  
 
Background and Aims  
Hypertension is a common complication of ADPKD. A role of 
the renin-angiotensin system (RAS) has been proposed, but 
human studies have shown conflicting results in correlation 
between plasma renin activity and blood pressure in ADPKD. The 
aim of this study was to investigate the role of renin-angiotensin 
pressor and kallikrein-kinin-prostaglandins depressor systems in 
the development of hypertension in ADPKD. 
 
Methods   
42 patients with ADPKD and hypertension aged 19-64 years old 
(mean age 39.9±2.7 years) were studied. Final diagnosis of 
ADPKD was based on decreased renal function signs, 
ultrasonography and CT. Renal angiography was performed in 16 
patients in order to make a differential diagnosis of arterial 
hypertension to further determine pressor and depressor agent 
activity in renal venous blood (RVB). Renin activity, angiotensin 
I (ANGI) and prostaglandin (PGF2α, PGE2) content were defined 
using radioimmune assays and the Hestrin method for kallikrein. 
 
Results 
Results in right and left renal veins (RRV/LRV). 
Renin activity (ng/ml/h)–
RRV:5.88±0.41;LRV:5.86±0.50;control: 02,-2,7 
ANGI content (ng/ml)
RRV:3.67±0.04;LRV:3.51±0.33;control::0,5 
PGF2α content (ng/ml) RRV:1.20±0.02;LRV:1.15±0.01 
PGE2 content (ng/ml)-RRV:3.9±0.14;LRV:4.44±0.24 
Kallikrein (mmol/l)
RRV:5.22±1.02;LRV:6.77±1.2;control:4.14±0.18 
 
Conclusions  
Renin activity and ANG1 content in RVB are increased 
statistically identically on both sides specifying the activation of 
a pressor system. Normal PGF2α content also confirms the 
activated RAS pressor corresponding to hypertension. Kallikrein 
concentration, but especially PGE2 content specifies the raised 
synthesis of PGE2 and preserved high activity of depressor agents 
in this group. Thus, the obtained results have shown not only main 
role of RAS but more there very impotent role of depressor agents 
in the pathogenesis of hypertension where the adequate synthesis 
of depressor agents can explain the mild course of hypertension 
in ADPKD. 
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CUFF METHODS FOR 24 HOUR BLOOD PRESSURE  
MEASUREMENT INDUCE AROUSAL REACTIONS 
DURING SLEEP COMBINED WITH BLOOD PRESSURE 
ELEVATIONS 
 
Andreas Patzak1, Ulrich Tönnesmann2 
1 Institute of Vegetative Physiology, Charité-Universitätsmedizin 
Berlin, Germany 
2 Reha-Zentrum Todtmoos, Klinik Wehrawald, Germany 
 
Background: The 24 hours cuff based blood pressure 
measurement is widely used for the diagnosis of hypertension. An 
important advantage, compared to traditional cuff methods, is the 
long-term measurement of blood pressure. However, the 
measurement is not continuous, which limits its application in 
sleep diagnostics. Another disadvantage in this context might be 
the mechanical stress of inflated cuffs. Here we hypothesized that 
inflation of the cuff induces disturbances of heart and circulatory 
control via an arousal reaction during sleep.  
Methods: To test the hypothesis, nine patients were 
polysomnographically investigated (SOMNOscreen, 
Somnomedics, Germany). EEG, EOG, EMG, heart rate, snoring, 
and the systolic blood pressure, via determination of the pulse 
transit time, were continuously monitored. Ambulatory blood 
pressure was measured using a device from spacelabs healthcare, 
USA. Results: We observed 107 micro arousals related to the 
inflation of the cuff in the patients. Micro arousals were 
characterized by significant increases of the mean EEG frequency 
and heart rate. Most important, the systolic blood pressure also 
increased significantly. Remarkably, the inflation of the cuff did 
not affect cardiovascular control during the waking state. 
Conclusion: Inflation of the cuff can influence the measurement 
of the blood pressure by inducing micro arousals. This can lead 
to false positive results. The finding is important in view of 
ambulatory blood pressure monitoring and for blood pressure 
measurement in sleep laboratories. 
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AGREEMENT BETWEEN CLINIC BP AND 24-HOUR 
AMBULATORY BP MEASUREMENTS 
 
W. W. Zhang1,2, Dominique. A. Cadilhac1,6, Leonid Churilov1 , 
Geoffrey. A. Donnan2,4, Christopher. O’Callaghan2,5, H. M. 
Dewey1,2,3 
1National Stroke Research Institute, Florey Neuroscience 
Institutes, Victoria, Australia 
2Department of Medicine, University of Melbourne, Victoria, 
Australia 
3Neurology Department, Austin Hospital, Victoria, Australia 
4Florey Neuroscience Institutes, Victoria, Australia 
5Clinical Pharmacology, Austin Health, Victoria, Australia 
6Monash medical center, Victoria, Australia 
 Background: Although ambulatory blood pressure (BP) 
monitoring is considered superior to a clinic-based measurement, 
the relationship between them has not been well addressed. 
Agreement analysis is used to uncover systematic differences 
between two measurement methods, not to identify similarities. 
Methods: Patients with TIA/minor stroke recruited within 7 days 
after onset and age-sex group matched control participants were 
monitored using a standard clinic BP measurement protocol and 
24-hour ambulatory BP monitor (Spacelab 90217). Lin’s 
concordance coefficient and the reduced major axes regression 
were used to calculate the agreement between each BP 
measurement type. Results: There were 158 subjects recruited; 76 
patients (mean age 68 years, 59% male) and 83 controls (mean 
age 66 years, 54% male). The mean clinic BPs were generally 
higher than the mean 24-hour ambulatory BPs (net difference: 
16/7 mmHg for patients and 10/4 mmHg for controls). A poor 
agreement between them was identified: SBP: Rho = 0.5 (95%CI 
0.4–0.6); Slope = 1.36, Intercept = -29.76; DBP r =0.7 (95% CI, 
0.6 to 0.8), slope = 1.0, intercept = 4.8. There was a proportional 
increase in the difference between the two measurements as SBP 
increased, and a fixed difference in DBP. Conclusion: The 
agreement between clinic BP measurement and 24-h ambulatory 
BP measurement was found to be poor for both SBP and DBP. 
For people with high systolic BPs, ambulatory BP measurement 
is recommended. Further large trials are needed to confirm these 
findings. 
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CHANGE IN PULSATILE CEREBRAL ARTERIAL 
PRESSURE AND FLOW WAVES AS A THERAPEUTIC 
TARGET  
 
Audrey Adji1,2, Miok Kim1, Michael O’Rourke2,3, Alberto 
Avolio1, Peter Smielewski4, John D Pickard4, Marek Czosnyka4 
1Australian School of Advanced Medicine, Macquarie University, 
Sydney, NSW 
2St Vincent’s Clinic, Sydney, NSW;  3University of New South 
Wales/ VCCRI, Sydney, NSW 
4Academic Neurosurgical Unit, Addenbrooke’s Hospital, 
Cambridge University, UK 
 
Background: Present concepts on central blood flow following 
brain trauma do not account for hemodynamic findings. 
 
Methods: Eight unconscious, paralysed, ventilated, patients with 
15-30 minutes spontaneous intracranial pressure (ICP) elevation 
(“plateau waves”) were studied in the Head Injury ICU of 
Addenbrooke’s Hospital following brain trauma. Radial intra-
arterial pressure (RP), ICP with Codman intraparenchymal 
sensor, and middle cerebral artery (MCA) flow velocity (bilateral, 
transcranial Doppler) were measured. RP waves were converted 
to aortic pressure (AoP), using SphygmoCor MX™, and the AoP 
wave onset was advanced to correspond to MCA flow onset. 
Cerebral perfusion pressure (CPP) was measured as instantaneous 
[AoP – ICP].  Recordings were taken before and at the peak of 
slow ICP plateau waves. 
 
Results: With elevation of mean ICP (28 to 53 mmHg; p<0.001), 
mean CPP (60 to 37 mmHg; p<0.001), and mean MCA flow 
velocity (53 to 42 cm/s; p<0.01) were reduced.  No significant 
change in AoP was found.  Simultaneous changes in pulsatile 
phenomena included increase in amplitude of ICP fluctuations 
(7.8 to 18.1 mmHg, p<0.01) and change in the ICP waveform to 
resemble AoP, with peak in late systole but augmentation 
relatively higher.  Findings are atrributable to compression and 
narrowing of brain blood vessels by rising cerebral volume and 
ICP, together with ill-effects of early wave reflection from the 
lower body.   
 
Conclusions: Hemodynamic monitoring supports the value of 
measures such as decompressive craniectomy to reduce elevated 
ICP and vascular narrowing, and of vasodilator therapy to reduce 
peripheral wave reflection. 
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PARTICLE IMAGE VELOCIMETRY ENABLES NON-
INVASIVE AND REPEATABLE MEASUREMENT OF 
BLOOD FLOW AND WALL SHEAR-STRESS IN 
RETINAL MICROVASCULATURE 
 
R Aidan Jamison1, A Fouras1, Bang V. Bui2, Zheng He2 and 
James A. Armitage3,4 
1Department of Mechanical and Aerospace Engineering, Monash 
University Clayton, 2Department of Optometry and Vision 
Sciences, The University of Melbourne 3Department of Anatomy 
and Developmental Biology, Monash University, Clayton, 
Australia 4Baker IDI Heart and Diabetes Institute, Commercial 
Road, Prahran, Australia  
 
Introduction: Microvascular dysfunction is central to the 
aetiology of cardiovascular disease but techniques to monitor the 
progression of microvascular disease are limited because non-
invasive, absolute quantification of blood flow and wall shear 
stress (WSS) is not possible.  
 
Objective: To develop a non-invasive methodology which 
enables absolute quantification of WSS and blood flow. 
 
Methods: Sprague-Dawley rats (n=6) were anaesthetised (2-4% 
isoflurane) and placed in a heated restrainer. The optical power of 
the cornea was negated and retinal microvasculature visualised 
(at 12x) via a Leica MZ16F dissecting microscope. Global motion 
of erythrocytes in second order (100µm) retinal arteries and veins 
was captured at 1500 frames/sec (12-bit greyscale, Y6 camera, 
IDT, USA) and particle image velocimetry image analysis used 
to calculate erythrocyte velocity from which flow and WSS were 
derived. Blood flow and WSS responses to acute phenylephrine 
induced increases and sodium nitroprusside induced decreases in 
systemic MAP were measured over a 100mmHg range. 
 
Results: Basal mean flow rate in arteries was 18.5 µl.min-1 
(CV=36.9%) and mean maximum WSS =3566.5 s-1 (CV=18%). 
In veins, mean flow rate was 17.8 µl.min-1 (CV=21.1%) and mean 
maximum WSS = 2119.0-1 (CV=11%). Whilst blood flow varied 
dramatically with systemic blood pressure (0 to 65.6 µl.min-1), 
WSS remained constant until systemic MAP fell by over 
25mmHg.  
 
Conclusions: Particle image velocimetry of erythrocyte motion in 
retinal microcirculation allows non-invasive quantification of 
blood flow and WSS and lends itself to longitudinal applications. 
WSS is more tightly regulated than flow and may be a useful 
parameter to track microvascular function longitudinally. 
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PODCAST: PREVENTION OF DECLINE IN COGNITION 
AFTER STROKE TRIAL: A FACTORIAL RANDOMISED 
TRIAL OF BLOOD PRESSURE AND LIP LOWERING 
 
Philip Bath1, Cyrille Correia2, Lynn Stokes3 
1,2,3Division of Stroke, University of Nottingham, U.K.  
 
Rationale: Stroke and dementia are common, economically costly 
to society, and devastating to patients and their family. Elevated 
BP and cholesterol are common after stroke and may be 
associated with increasing cognitive decline. Although BP-
lowering post-stroke may reduce cognitive decline, there is little 
evidence that lipid lowering is effective in preventing cognitive 
decline. Critically, it is unknown whether BP and cholesterol 
should be lowered intensively, or moderately as per current 
guidelines. The trial aim is to determine if intensive BP and/or 
lipid lowering therapy after stroke is better in preventing 
cognitive decline, compared to current guideline treatment.  
 
Design: PODCAST is a prospective, randomised, open-label, 
blinded end-point, controlled, partial factorial, phase IV trial. The 
start up phase will assess feasibility of the study over 3 years in 
600 patients. The main phase will assess the efficacy of intensive 
treatment in a further 2,800 patients over 8 years in total. The 
target Systolic Blood Pressure is <125 mmHg for the intensive 
BP lowering group and <140 mmHg for the guideline group. For 
the intensive lipid lowering group the target Low Density 
Lipoprotein-Cholesterol (LDL-C) is <2 mmol/L and <3 mmol/L 
for the guideline group. The primary outcome is Addenbrooke’s 
Cognitive Examination. Secondary outcomes include vascular 
events, quality of life, functional outcome, depression and death. 
 
Trial status: The trial has UK Ethics and NHS RD approvals and 
has recruited 27 patients to date.  
 
Funding: The start-up phase is funded jointly by The Stroke 
Association UK and Alzheimer’s Society UK. 
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TILT TABLE TESTING IN PATIENTS WITH 
SUSPECTED EPILEPSY 
 
Joao Freitas1,2, Ines Rangel1, Rosa Santos1, Maria Julia Maciel1, 
Francisco Rocha Gonçalves2 
1Centro Hospitalar São João – EPE, Porto, Portugal; 
2Faculdade de Medicina do Porto, Portugal 
 
Background 
Around 20% to 30% of epileptic patients may have been 
misdiagnosed and neurocardiogenic syncope (NCS) is probably a 
frequent mistaken cause. 
 
Methods 
We retrospectively analyzed clinical records of 107 patients with 
previous epilepsy and medicated with antiepileptic drugs, who 
were referred for HUTT, in the period from January 2000 to 
December 2010.  
 
Results 
Among all, 73 (68 %) patients were women with a mean age of 
38 ± 17 years. HUTT was positive in 67 (63%) patients. Follow-
up data were available in 94 (88%) patients, with a mean follow-
up period of 72 months. Thirty-three (35%) patients previously 
diagnosed with epilepsy were found to be misdiagnosed (positive 
HUTT and clinical features not consistent with epilepsy). 
Twenty-one (22%) patients had dual diagnosis of NCS and 
epilepsy (HUTT positive but presence of clinical features 
supporting epilepsy). There was no significant difference in the 
type of HUTT response between the misdiagnosed group and the 
dual diagnosis group (p>0,05).Misdiagnosed patients (isolated 
NCS with typical clinical reproduction at HUTT) stopped taking 
antiepileptic medication and 15% of them received new 
pharmacological treatment (midodrine or B-blocker) and most 
were reassured and advised to increment salt and water intake and 
perform physical countermanouvres. Syncope recurrence was 
reported in 57% of the patients. No relevant difference between 
positive and negative HUTT groups (49% vs 69%; p>0,05) were 
observed but it was significantly lower in the misdiagnosed group 
of patients (42% vs 64%; p=0.037). 
 
Conclusion 
NCS is frequently an important cause of epilepsy misdiagnosis. 
HUTT is often crucial to make an accurate diagnosis and to select 
the appropriate treatment in patients presenting with transient loss 
of consciousness to reduce recurrence. 
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TRANSCRANEAL DOPPLER EVALUATION DURING 
HEAD-UP TILT CHALLENGE 
  
Joao Freitas1, Pedro Castro2, Rosa Santos1, Elsa Azevedo2, Maria 
Julia Maciel1, Francisco Rocha Gonçalves2. 
1Centro Hospitalar São João – EPE, Porto, Portugal; 2Faculdade 
de Medicina do Porto, Portugal 
 
Background:  
Neurally mediated syncope (NMS) pathophysiology is still 
controversial. Interest shifted from cardiac to central 
mechanisms, particularly concerning cerebral autoregulation. 
Attention has mainly focused in the perisyncopal period. Our 
study aimed to compare cerebral hemodynamics in supine, initial 
and final head-up tilt (HUT) in NMS and healthy subjects. 
 
Methods:  
12 NMS and 12 control subjects were studied in supine position 
for 10 minutes and in 70° HUT for 45 minutes or till syncope. 
They were monitored with transcranial Doppler for bilateral 
middle cerebral artery (MCA) blood flow velocities (BFV) and 
with Finapres for noninvasive continuous arterial blood pressure 
(BP). Mean BFV,cerebrovascular resistance index (CVRi) and 
mean BP were compared between supine, and minute-to-minute 
in the first and last 5 minutes of HUT. 
 
Results:  
One NMS and 3 controls subjects were excluded due to poor 
quality data. In the first minutes of HUT, both groups showed 
increase in BP and CVRi and decrease in BFV, although the 
temporal profile registered a more gradual response of BP and 
BFV in the NMS group, not reaching statistical significance. In 
the last 5 minutes of HUT, while controls had no hemodynamic 
changes, in NMS we observed a steady decrease of BFV (p<0.05) 
and increase of CVRi (p<0.05), before any BP change. 
 
Discussion:  
Paradoxical vasoconstriction in the minute preceding syncope has 
been consistently demonstrated in NMS, but we detected these 
changes at least five minutes before syncope. Furthermore, in the 
initial HUT period our NMS subjects showed a trend to delayed 
hemodynamic changes. These data are consistent with an 
abnormal adaptation profile to orthostatic stress in NMS that 
could be due to impaired autonomic nervous system control and 
cerebral autoregulation. 
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CEREBRAL HEMODYNAMIC AND 
ANTIHYPERTENSIVE DRUGS: ARE THERE ANY 
ADVANTAGES? 
 
Oksana Gulkevych 
National Scientific Centre “M.D.Strazhesko Institute of 
Cardiology of AMS 
of Ukraine”  
 
Objective: To evaluate the influence of different antihypertensive 
drugs such as beta-blockers, calcium channel blocker, ACE 
inhibitor on carotid structure and cerebral blood flow in essential 
hypertension (EH) patients (pts). 
Design and Methods: Doppler ultrasonography and 24h blood 
pressure monitoring were performed in 146 EH pts (48,8±0,94 
years; 108males) before and after 12 weeks antihypertensive 
treatment. Diameter of the common carotid artery (DCCA), 
common carotid intima-media thickness (CCIMT), systolic 
(Vmax) and diastolic (Vmin) blood flow velocity in CCA and 
medium cerebral artery (MCA) were measured. The 
cerebrovascular resistance index (CVRI) was calculated using 
measurements from Doppler ultrasonography of CCA, MCA and 
systemic blood pressure. All pts were divided to Carvedilol 25-
50mg (n=37), Betaxolol 10-20mg (n = 41), Amlodipin 2,5-5mg 
(n = 34), Spirapril 6mg (n = 34) treatment. Statistical analysis was 
performed by pair variant method. 
Results: Decrease of blood pressure was similar with all four 
drugs. However, Betaxolol, Amlodipin, Spirapril decreased 
DCCA (accordingly: -8%, p<0,05; -4%, p<0,05; -3%, p<0,05) 
and Carvedilol increased it (+3%, p<0,05). The CCIMT was 
decreased significantly with Betaxolol and not significantly with 
other drugs. All drugs did not significantly change blood flow 
velocities in CCA but in MCA they significantly increased 
initially low Vmin. The CVRI of CCA and MCA were 
significantly decreased with all drugs. 
Conclusion: In spite of different influence on carotid structure all 
used drugs significantly improved the cerebral hemodynamic by 
decreasing cerebral vessels resistance. These positive effects are 
caused by blood pressure reduction. 
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AUTOPHAGY CASCADE CORRELATES WITH 
PHENOTYPIC ALTERATION OF NEUROVASCULAR 
ENDOTHELIUM IN A MOUSE MODEL OF ALZHEIMER 
DISEASE 
 
Shinichiro Hayashi1, Naoyuki Sato2, Ryuichi Morishita2, Yuhei 
Kawano1 
1National Cerebral and Cardiovascular Center, Japan. 2Osaka 
Graduate School of Medicine, Japan. 
 
Background:  
Alzheimer disease (AD) is characterized by progressive neuronal 
disorder that cause dementia, and is recognized as a major cause 
of death in the elderly population. Recent our in vitro findings 
suggest the possible involvement of autophagy-associated 
endothelial dysfunction in the pathogenesis of AD. 
 
Methods:  
To investigate whether autophagy cascade affects phenotype 
alteration of neurovascular endothelium in the development of 
AD, electron microscopy (EM) and immunohistological analysis 
were performed on brain tissues of APP23, a mouse model of AD, 
and age-matched wild type mice. 
 
Results:  
The Morris water maze test showed cognitive disturbance in 8-
month old APP23 mice but not in wild type mice. Interestingly, 
EM revealed that the densities of hippocampal capillary were 
significantly lower in APP23 mice as compared to those in wild 
type mice. The reduction in hippocampal microvessels was more 
apparent in 24-month old APP23 mice. Immunostaining with 
antibodies against ß-amyloid (Aß) and alpha-smooth-muscle-
actin showed that Aß deposition was not limited to neural cells 
but to microvessels in hippocampus and cortex. Notably, EM 
analysis revealed autophagy induction in hippocampal capillary 
endothelium in 8-month old APP23 mice.  In addition, the number 
of microvessels with autophagic endothelium was significantly 
increased in 24-month-old APP23 mice. Furthermore, the 
advanced stages of autophagy fused with lysosome were detected 
in both neurovascular endothelium and neural cells.  
 
Conclusions:  
Present results indicate that phenotypic alteration of 
neurovascular endothelium might be the earlier pathological 
events in brain with AD, suggesting important implications for 
therapeutic approaches of AD. 
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POSITRON EMISSION TOMOGRAPHY OF 18-
FLUORINE DEOXYGLUCOSE BRAIN DISTRIBUTION 
IN HYPERTENSIVE PATIENTS WITH AND WITHOUT 
OBSTRUCTIVE SLEEP APNEA SYNDROME 
 
Yurii Sviryaev1, Nadezhda Zvartau1, Lyudmila Korostovtseva1, 
Andrei Stanzhevskyi2, Alexandra Konradi1, Nikolai Kostenikov2  
1Almazov Federal Heart, Blood and Endocrinology Centre 
2Russian Research Institution of Radiology and Surgery 
Technology  
 
Background:  
Sleep apnea is known to be associated with the higher risk 
of stroke [Valham F. et al., 2008], and regional cerebral blood 
flow abnormalities could mediate this association. We assessed 
the peculiarities of regional cerebral blood flow in hypertensive 
patients with and without obstructive sleep apnea syndrome 
(OSAS).  
 
Design and methods:  
18-fluorine deoxyglucose (18 FDG) brain distribution was 
examined during wakefulness [Ecat Exact 47, Ecat Exact HR+, 
Germany, tissue metabolic activity was assessed by «Standard 
Uptake Value»] in 10 hypertensive subjects with OSAS and in 6 
non-OSAS hypertensives (matched by demographic and clinical 
parameters).  
 
Results:  
There were 5 areas of reduced 18-FDG accumulation in non-
OSAS subjects (left thalamus in 3 subjects, right thalamus in 5 
subjects, right and left caudate nucleus in one case, mediobasal 
areas of right temporal lobe in one case) compared to 12 areas in 
OSAS patients: left and right frontal lobes (one subject in each 
case); left and right parietal lobes (one subject in each case); 
anterior part of left cingulate gyrus (n=1); left and right 
subconvex area (n=3 and n=1); mediobasal areas of right 
temporal lobe (n=4); left and right caudate nucleus (n=5 and 
n=7); left and right thalamus (n=5 and n=6). Comparative 
analysis included only 2 regions: left thalamus (8.5±0.8 vs 
8.7±0.3 units, p>0.05), and right thalamus (8.3±0.9 vs 8.5±0.2 
units, p>0.05). OSAS patients had higher frequency of the 
reduced 18-FDG accumulation during wakefulness (χ2=4.46; 
р=0.07). 
 
Conclusions:  
Hypertensive subjects with OSAS seem to have higher 
frequency of cerebral loci with reduced metabolic activity. 
 
References:  
Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin 
KA. Increased risk of stroke in patients with coronary artery 
disease and sleep apnea: a 10-year follow-up. Circulation. 
2008;118(9):955-60.  
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THE ROLE OF CATECHOLAMINE UPTAKE 
PATHWAYS IN VASCULAR ABNORMALITIES 
ASSOCIATED WITH DEPRESSION-LIKE SYMPTOMS 
IN RATS 
 
Vladimir Matchkov1, Elena Bouzinova2, Ove Wiborg2, Christian 
Aalkjaer1 
1Department of Biomedicine, Aarhus University, Denmark, 
2Center for Psychiatric Research, Aarhus University Hospital, 
Denmark 
 
Background:   
Depression and cardiovascular disease are known to occur 
simultaneously but the reason for this is unclear. Interestingly, 
hypertension has been suggested in association with anti-
depressive treatment. In a chronic mild stress (CMS) model of 
depression only some rats develop depression-like symptoms 
(‘anhedonia’ evidenced by reduced sugar intake), while others are 
stress-resistant (‘resilient’).  
 
Methods:  
We have assessed in vitro isometric force in the middle cerebral 
(MCA) and mesenteric small arteries (MSA) from resilient and 
non-stressed rats, and anhedonic rats after 8 weeks CMS. Protein 
levels were quantified by Western blotting. 
 
Results:  
Anhedonic rats had a reduced cardiac output and unchanged 
blood pressure suggesting increase in total peripheral resistance 
(TPR).  
MSA from the three groups responded similarly to noradrenaline 
(NA) but the potentiating effect of the neuronal reuptake 
inhibitor, cocaine, was increased in anhedonic rats compared with 
resilient and non-stressed rats. This is in accordance with 
upregulation of the neuronal NA transporter (NET) protein in 
MSA from anhedonic rats. In contrast, corticosterone-sensitive 
extra-neuronal monoamine uptake was diminished in MSA after 
CMS. This was associated with a reduced expression of the OCT2 
transporter protein.  
MCA from anhedonic rats was more sensitive to serotonin (5-HT) 
in comparison with resilient and non-stressed rats. Cocaine and 
corticosterone  were without effect on 5-HT responses of MCA. 
 
Conclusions:   
Our results indicate that depression-like symptoms in rats are 
associated with changes in vascular catecholamine uptake 
pathways and sensitivity to agonists in a vascular bed specific 
manner. These changes can be important for the TPR elevation in 
anhedonic rats. 
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CEREBRAL PERFUSION AND COGNITIVE FUNCTION 
IN POST-STROKE PATIENTS WITH HYPERTENSION 
 
Shuji Matsumoto, Megumi Shimodozono, Kazumi Kawahira  
Kagoshima University     
 
Objective:  
To estimate cerebral perfusion and cognitive function in post-
stroke patients with hypertension before and after hypotensive 
therapy.  
 
Research design and methods:  
The treatment group comprised 28 post-stroke patients (mean age 
± standard deviation [SD], 57.8 ± 8.3 years) with previously 
untreated or ineffectively treated essential hypertension. All 
patients underwent brain xenon-enhanced computed tomography 
(Xe-CT) scanning and comprehensive neuropsychological 
testing, both before and after 24 weeks of hypotensive therapy 
using the angiotensin II receptor blocker (ARB) olmesartan 
medoxomil. The control group comprised 20 age-matched post-
stroke patients (mean age ± SD, 56.6 ± 8.5 years) without 
hypertension, carotid atherosclerosis, coronary artery disease, or 
psychiatric disorders.  
 
Results: 
The hypertensive patients had significantly lower levels of 
cerebral perfusion (4–8%) in all brain regions, a 25% decrease in 
attention and psychomotor speed, and an 18% decrease in 
mentation compared with the control subjects. Following 6 
months of hypotensive therapy, the hypertensive patients 
experienced an increase in cerebral perfusion by 8–15% in all 
brain regions, an 18–36% improvement in attention and 
psychomotor speed, and an average 19% improvement in abstract 
mentation.  
 
Conclusions:  
Hypertensive patients showed marked signs of cerebral 
hypoperfusion and impaired cognitive function, as indicated by 
decreased attention, reduced psychomotor speed, and slow 
mentation; however, these symptoms were improved by 24 weeks 
of hypotensive treatment with an ARB. 
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PULSE PRESSURE AMPLIFICATION PREDICTS 
MENTAL SPEED BEYOND BRACHIAL BLOOD 
PRESSURE 
 
Matthew P. Pase1, Andrew Pipingas1 
1Swinburne University of Technology, Hawthorn, Australia 
 
Background:  
Although brachial blood pressure (BP) is an established predictor 
of cognitive decline, the association between central pressure and 
cognition has received little attention.  This is surprising given 
that 1) brachial BP differs in magnitude to aortic pressure and 2) 
blood is delivered to the brain through the aorta and carotids and 
not the brachial artery. A relatively novel biomarker called Pulse 
Pressure Amplification (PPA) captures the discrepancy between 
central and peripheral BP yet has not been equated to cognitive 
outcomes.   
 
Methods:  
We examined the cross-sectional association between PPA and 
mental speed in 155 healthy participants aged 50-70 years. 
Participants completed computerized cognitive tests designed to 
assess simple and two-choice reaction time with millisecond 
precision. Brachial BP was measured three times and averaged 
before aortic BP was derived through applanation of the radial 
artery. PPA was calculated as peripheral/central pulse pressure.  
 
Results:  
In correlation analysis, higher PPA was associated with faster 
mental processing. Hierarchical linear regression indicated that 
PPA explained 6.8% of the variance in choice reaction time 
scores over and above brachial systolic pressure (β= -.27, ΔR2= 
0.68, p <0.001) and 7% beyond brachial pulse pressure (β= -.26, 
ΔR2= 0.07, p <0.001). When controlling for standard 
cardiovascular risk factors these relationships remained 
significant but were attenuated. PPA was not associated with 
simple reaction time above and beyond the combination of 
peripheral BP and cardiovascular risk factors. 
 
Conclusions:  
This study is perhaps the first to show that PPA predicts specific 
cognitive processes more so than brachial BP.   
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CARDIAC REPOLARIZATION- RELATIONS TO 
EXECUTIVE COGNITIVE FUNCTIONING IN THE 
SWEDISH WORKING POPULATION 
 
Cecilia Stenfors1,2, Lars-Göran Nilsson1, Töres Theorell2,5, Inga 
Jonsdotter4, Walter Osika2. 
1 Department of Psychology, Stockholm University 2 Stress 
Research Institute, Stockholm University 3 The Institute of Stress 
Medicine, Gothenburg 4 Department of Physiology, Sahlgrenska 
Academy, University of Gothenburg 5 Department of Physiology 
and Pharmacology, Karolinska Institute, Stockholm 
 
Background: 
Otherwise healthy persons in the work force may at times 
experience cognitive symptoms, such as difficulties in focusing 
attention, thinking clearly, in remembering adequately and in 
making decisions in their jobs and elsewhere. 
We have previously shown that cognitive symptoms in the 
working population is related to lower ability in executive 
functions required in working memory tasks. However, it is not 
known whether this lower cognitive ability is linked to 
physiological stress/allostatic load. 
As sympathetic activity is a key component in both dynamic and 
cumulative stress responses, the aim of the current study was to 
test the relation between measures of autonomic regulation of 
sympathetic activity- cardiac repolarization variability (QTVI)- 
and cognitive functioning, using cognitive tests that are sensitive 
to effects that are caused by stress. 
 
Method: 
233 (116 cases) male and female participants were drawn from 
the general gainfully employed Swedish population (from the 
Swedish Longitudinal Occupational Survey of Health) reporting 
either a high or a low level of cognitive symptoms. For all 
participants, ECG recordings and neuropsychological testing 
covering different cognitive domains, including executive 
functions, were performed.  
 
Results: 
In women, but not in men, cardiac repolarization variability was 
related to poorer ability in executive functions that are required in 
working-memory tasks while being unrelated to others, after 
controlling for demographical factors. 
 
Conclusion:  
Autonomic dysregulation of sympathetic activity may be both 
partly driven by- as well as negatively affect- poor executive 
cognitive ability.  These factors may together drive the 
development of hypertension among women in the working 
population. 
 
 
 
POSTER SESSION P3: NOVEL VASCULAR 
THERAPEUTIC TARGETS 
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TM5441, a novel PAI-1 inhibitor, protects against the 
development of hypertension, hypertrophy, and fibrosis due 
to NOS inhibition 
 
Amanda E. Boe1, Mesut Eren1, Sheila B. Murphy1, Christine E. 
Kamide1, Toshio Miyata2, and Douglas E. Vaughan1 
1Northwestern University, Chicago, IL and 2Tohoku University, 
Sendai, Japan 
 
Background: Long-term inhibition of nitric oxide synthase (NOS) 
by L-arginine analogues such as Nω-nitro-L-arginine methyl ester 
(L-NAME) has previously been shown to induce hypertension 
and perivascular fibrosis in animal models. NOS inhibition is also 
known to induce the expression of plasminogen activator 
inhibitor-1 (PAI-1) in vascular tissue. Our lab previously reported 
that PAI-1 deficient mice (PAI-1-/-) were protected against 
hypertension and vascular fibrosis due to long-term L-NAME 
treatment.  These findings led to the hypothesis that 
pharmacological inhibition of PAI-1 activity is protective against 
the L-NAME-induced hypertension in wild-type (WT) mice.  In 
this study, we investigated the effects of TM5441, a novel PAI-1 
antagonist, on systolic blood pressure, hypertrophy, and 
periaortic fibrosis. 
 
Methods and Results: WT C57BL/6 mice and TM5441-treated 
animals (20mg/kg/day) were administered L-NAME (1mg/mL) 
for 8 weeks. Systolic blood pressure (SBP) measurements were 
taken every 2 weeks. After 8 weeks, we found that TM5441 
significantly attenuated the development of hypertension 
compared to animals that had received L-NAME alone (SBP 
162.62±21.18 vs. 182.99±13.21 mm Hg, p=0.009).  We also 
observed significant reductions in left ventricle wall thickness 
(p=0.03) and mass (p=0.02).  Additionally, TM5441-treated mice 
had a 34% reduction in periaortic fibrosis relative to WT animals 
on L-NAME (p=0.003).  
 
Conclusions: Pharmacological inhibition of PAI-1 is protective 
against the development of hypertension, hypertrophy, and 
periaortic fibrosis in mice treated with the NOS inhibitor L-
NAME.  These findings indicate that PAI-1 inhibition can offer a 
novel therapeutic approach in the prevention of hypertension 
caused by conditions or risk factors that induce endothelial 
dysfunction in humans. 
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EFFECTS OF A POTENT ANTIOXIDANT ON 
VASCULAR FUNCTION IN CVD PATIENTS AND 
VOLUNTEERS 
 
Parag Gajendragadkar1, Annette Hubsch1, Kaisa Mäki-Petäjä1, 
Martin Serg2, Ian Wilkinson1, Joseph Cheriyan1 
1 Clinical Pharmacology Unit, University of Cambridge, 
Cambridge, UK.,  
2 Department of Cardiology, University of Tartu, Tartu, Estonia. 
 
Background: Lycopene is a powerful anti-oxidant in tomatoes. 
We investigated its effects on vascular function by oral 
supplementation. 
 
Design: 36 stable cardiovascular disease (CVD) patients on 
statins and 36 healthy volunteers (HV) were randomised to 7mg 
lycopene (Ateronon) or placebo daily for 2 months (Clintrials 
NCT01100385). Forearm blood flow responses to acetylcholine 
(ACh - endothelium dependent vasodilatation; EDV), sodium 
nitroprusside (endothelium independent vasodilatation; EIDV) 
and L-N-monomethyl-arginine (basal NO synthase) were 
measured using venous plethysmography, arterial stiffness 
(Sphygmocor), blood pressure (BP) and serum biomarkers were 
measured pre- and post therapy. 
 
Results: Both groups were well matched (CVD - age 67±5 vs. HV 
- 64±11), although the CVD group had a higher clinic systolic BP 
(138±10 vs. 125±15 mmHg, P<0.001) and higher central systolic 
BP (128±10 vs. 116±16mmHg, P<0.001). At baseline, the CVD 
group had impaired EDV to ACh compared with HV (30% lower; 
95% CI: -45% to -10%, P=0.008). Lycopene improved EDV in 
CVD patients by 53% (95% CI: +9% to +93%, P=0.03 vs. 
placebo) but not EIDV or NO. No change was seen in EDV, 
EIDV or NO responses in HV. BP, BP variability, arterial 
stiffness, LDL and hs-CRP did not change in lycopene treated 
groups. After lycopene treatment, CVD patients had similar EDV 
responses compared to HV at baseline (3% lower; 95% CI: -30% 
to +30%, P=0.85) suggesting normalisation of vascular function 
(see Figure). 
 
Conclusion: Lycopene improves vascular function in patients 
with stable CVD. This was not due to effects on conventional 
cardiovascular risk factors. Further studies are warranted. 
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ENDOTHELIN-1-INDUCED OXIDATIVE STRESS AND 
INFLAMMATORY CELL INFILTRATION ARE 
ASSOCIATED WITH EXAGGERATED 
ATHEROSCLEROSIS IN HIGH-FAT DIET-FED 
APOLIPOPROTEIN E KNOCKOUT MICE 
 
Melissa Wei Li1,3, Daniel A. Kasal1, Talin Ebrahimian1, Pierre 
Paradis1,3, Ernesto L. Schiffrin1,2,3 
1Lady Davis Institute for Medical Research 
2Department of Medicine, Sir Mortimer B. Davis-Jewish General 
Hospital 
3McGill University 
 
Background: Endothelin (ET)-1 plays an important role in 
generation of reactive oxygen species (ROS) and inflammation in 
the vasculature. ET-1has been implicated in the pathogenesis of 
atherosclerosis since plasma and tissue ET-1 are increased in 
human and animal models of atherosclerosis. We observed that 
ET-1 overexpression exacerbates high-fat diet (HFD)-induced 
atherosclerosis in apolipoprotein E knockout (apoE-/-) mice. We 
hypothesized that ET-1-induced ROS and inflammation 
contribute to the development of atherosclerosis. 
 
Design and methods: Eight-week-old male transgenic mice 
overexpressing preproET-1 in the endothelium (eET-1), apoE-/-, 
eET-1/apoE-/- and wild type mice were fed a HFD for 8 weeks. 
Aortic atherosclerotic lesions were quantified using Oil Red O 
staining. ROS production using dihydroethidium staining and 
monocyte/macrophage and T cell infiltration using 
immunofluorescence with MOMA-2 and anti-CD4 antibodies, 
respectively, were determined in perivascular fat, media and 
plaque in ascending aortic sections. 
 
Results: eET-1/apoE-/- presented 3.8-fold more atherosclerotic 
lesions in whole aorta compared to apoE-/- (P<0.01). ET-1 
overexpression caused 2.6-, 1.9- and 1.9-fold increase in ROS 
production in perivascular fat, media and plaque of apoE-/-, 
respectively (P<0.05). ET-1 overexpression increased 
monocyte/macrophage infiltration by 5- and 8-fold in 
perivascular fat and media, respectively (P<0.05). CD4+ T cell 
infiltration was observed in perivascular fat and plaque of 3 and 
5 of 6 eET-1/apoE-/- compared to 0 and 1 of 6 apoE-/-, respectively 
(P<0.05). 
 
Conclusions: The results suggest that ET-1 play an important role 
in progression of atherosclerotic lesions by increasing the 
oxidative stress and monocyte/macrophage and T cell infiltration 
in the atherosclerotic aorta, including the perivascular fat. 
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LOWERING OF BINDING AFFINITIES OF AGONISTS 
TO THEIR RECEPTORS BY INHIBITION OF Rho-
ASSOCIATED KINASE (ROCK) IN RAT AORTA 
 
Takaki Yamamura, Tetsuya Sakajiri 
Faculty of Nutritional Sciences, The University of Morioka 
 
Sustained smooth muscle contraction is mediated by extracellular 
Ca2+ influx through L-type Ca2+ channels and RhoA/ROCK-
dependent Ca2+ sensitization, accepting stimulatory signals 
initiated by agonists through G protein-coupled receptors. In this 
study, in isolated rat aortic rings, the MLCK inhibitor wortmannin 
(WM) of 10μM, which completely abolished high K+-evoked 
contraction, left 8%, 6%, or 17% of the contraction induced by 
100nM endothelin (ET)-1, 1μM norepinephrine (Nep), or 3μM 
U46619 (thromboxane analog), respectively. These remaining 
contractions were completely abolished by application of the 
ROCK inhibitor Y-27632 of 10μM. Therefore, the WM-
insensitive contractions were suggested to be caused by direct 
phosphorylation of MLC by ROCK. The contraction induced by 
ET-1 or Nep was incompletely depressed by application of the 
ETA receptor antagonist BQ-123 of 1μM or the α1-adrenergic 
receptor antagonist prazosin of 1nM, respectively. The ET-1- and 
U46619-evoked contractions were slowly relaxed by rinsing the 
muscle rings with the solution without agonists. The agonist-
evoked contractions were also incompletely or slowly depressed 
by 1~10μM Y-27632. However, combination of Y-27632 with 
corresponding antagonists and muscle-rinsing with solution 
containing Y-27632 produced rapid and complete relaxation of 
the contractions. The reduction effect of 10nM nifedipine or 
10μM verapamil on the contractions was enhanced co-treatment 
with Y-27632. The combination treatment of Y-27632 and WM 
did not produce such synergistic inhibition of the contractions. 
These results suggested that the RhoA/ROCK pathway is not only 
involved in the Ca2+ influx, but also in binding affinities of 
agonists to their receptors. 
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ASSOCIATION OF ESTROGEN SYNTHESIS GENES; 
CYP19A1, HSD3B1 AND HSD3B2 WITH HYPERTENSIVE 
DISORDERS IN PREGNANCY 
 
Masanori Shimodaira1,2, Tomohiro Nakayama2,3, Ichiro Sato4, 
Naoyuki Sato2, Noriko Izawa5, Yoshihiro Mizutani6, Kiyohide 
Furuya4, Tatsuo Yamamoto4 
1 Departments of Internal Medicine, Iida Municipal Hospital, 
Nagano, Japan, 2 Division of Laboratory Medicine, Department 
of Pathology of Microbiology, Nihon University School of 
Medicine, Tokyo, Japan, 3Divisions of Nephrology and 
Endocrinology, Department of Medicine, Nihon University 
School of Medicine, Tokyo, Japan, 4Department of Obstetrics and 
Gynecology, Nihon University School of Medicine, Tokyo, Japan, 
5Division of Genomic Epidemiology and Clinical Trials, 
Department of Advanced Medical Science, Nihon University 
School of Medicine, Tokyo, Japan, 6Department of 
Ophthalmology, Nihon University School of Medicine, Tokyo, 
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Background: Hypertension in pregnancy is a multifactorial 
disorder caused by a complex combination of environmental 
factors and several predisposing genes. Because estrogen 
modulates placental vascular development, estrogen synthesis 
genes are considered to be plausible candidate genes for 
hypertension in pregnancy.  
 
Objectives: This haplotype-based case-control study aimed to 
estimate whether polymorphisms in maternal estrogen synthesis 
genes (CYP19A1, HSD3B1, and  HSD3B2) are associated with 
preeclampsia and gestational hypertension. Methods: In 69 
preeclampsia and 62 gestational hypertension patients and 155 
age-matched, primiparous, healthy controls, genotyping of 5 
single nucleotide polymorphisms (SNPs) of CYP19A1 
(rs1870049, rs936306, rs700518, rs700519, and rs4646), 3 SNPs 
of HSD3B1 (rs3765945, rs6203, and rs1047303), and 2 SNPs of 
HSD3B2 (rs2854964 and rs1819698) was performed using 
TaqMan SNP allelic discrimination methods. Results: For 
rs700158 of CYP19A1, the frequencies of the AG + GG genotype 
and G allele were significantly higher in preeclampsia patients 
than in controls (P = 0.037, and P = 0.033, respectively). Logistic 
regression analyses indicated that the AG + GG genotype of 
rs700158 was a risk factor for preeclampsia (odds ratio = 2.15, P 
= 0.026). In addition, the frequency of the G–G haplotype 
constructed using rs700518–rs4646 was also significantly higher 
for preeclampsia (P = 0.017). However, polymorphisms in 
HSD3B1 and HSD3B2 were not associated with hypertension in 
pregnancy. Conclusions: We confirmed that rs700158 of 
CYP19A1, as well as the haplotype constructed using rs700518 
and rs4646 are useful genetic markers of preeclampsia in the 
Japanese population. 
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THE EFFECT OF RAAS BLOCKADE AGENT ON 
CONTRAST MEDIUM INDUCED ACUTE KIDNEY 
INJURY(CIAKI) AFTER CORONARY ANGIOGRAPHY 
 
Taeik Kim1, Mikyung Kim2 
1Maryknoll Medical Center, Pusan, Korea, 2Inje University, 
Pusan, Korea 
 
Background: The effect of RAAS blockade agent on CIAKI has 
not been clarified yet, therefore we tried to find out the effect of 
RAAS blockade on CIAKI after coronary angiography. 
 
Design and methods: We reviewed charts of patient performed 
coronary angiography in our hospital from May 2009 to July 
2011. The groups of patients with RAAS blockade agent 
(RAAS(+)) and without (RAAS(-)) were total 414 and 1058 case, 
respectively. 
 
Results: Among patients without diabetes mellitus, development 
of CIAKI depending on treatment with RAAS blockade within 
72hours were higher (HR 1.47, P=0.019). 
In subgroup analysis for patients with diabetes mellius , 
development of CIAKI depending on treatment with RAAS 
blockade was not different (HR 1.04, P=0.881). 
  
Conclusion: Among patients without diabetes mellitus, using 
RAAS blockade agents before coronary angiography may have 
harmful effect on CIAKI compared to not using that medication 
after adjusting all other risk factors of CIAKI. In sub-analysis for 
patients with diabetes subjects, that harmful effect of RAAS 
blockade on CIAKI was not observed. 
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24 HOUR URINARY EXCRETION OF SALT IN 
MONGOLIANS 
 
Tserennadmid Enkhjargal1, Batsaikhan Enkhtungalag1, Batbayar 
Sodnomtseren1, Enkhbold Tuya1, Jamyan Batjargal1, Davaakhuu 
Narantuya2, Bayandorj Tsogzolmaa2, Mary-Anne Land3, Jacqui 
Webster3 
1Public Health Institute, Ulaanbaatar, Mongolia 
2WHO, Mongolia; 3George Institute, Sydney, Australia 
 
Background:  
Hypertension is a main risk factor for cardiovascular diseases in 
Mongolia. There is strong evidence for a direct relationship 
between dietary sodium consumption and blood pressure. Salt 
intake can be estimated by measuring urinary excretion of 
sodium.  
 
Methods:  
24-hour urine samples were collected from 983 adults 25-64 
years of age from Ulaanbaatar, the capital city of Mongolia and 
four provinces. The urinary level of sodium was determined 
using the ion-selective method, and the amount of salt was 
calculated based on the urinary concentration of Na. 
 
Results:  
The mean urinary concentration of salt was 11.1 g/day. There 
was no statistically significant difference in the excreted amount 
of salt detected between males and females (11.3 g/day vs. 10.8 
g/day, p>0.05)or between adults living in the capital city and 
those living in the rural provinces (11.5 g/day vs. 10.7 g/day, 
p>0.05) or between the age groups (9.8 g/day in the 25 to 34 
year age group; 11.5 g/day in adults aged 35 to 44; 11.5 g/day in 
45-54-year-old participants and 11.7 g/day in the 55 to 64 age 
group, p>0.01).  
 
Conclusions:  
The survey results demonstrate that the salt intake per day of 
Mongolians is higher than that of other populations and is more 
than twice the WHO target intake of 5g of salt per day. This 
highlights the need for a population salt reduction strategy and 
provides a solid baseline from which to monitor future change. 
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TREATMENT GOALS AND PITFALLS IN THE 
MANAGEMENT OF HYPERTENSION 
 
Robert H. Fagard 
Hypertension and Cardiovascular Rehabilitation Unit, 
Department of Cardiovascular Diseases, KU Leuven University, 
Leuven, Belgium 
 
In the last decade, guidelines on the management of hypertension 
have recommended a goal of < 140/90 mmHg for office blood 
pressure in hypertensive patients at low-to-moderate risk, and a 
goal of < 130/80 mmHg in patients at high risk because of 
diabetes, cardiovascular, cerebrovascular or renal disease. 
However, more recent insights have led to a reappraisal of these 
recommendations, namely that the goal blood pressure of < 
140/90 mmHg can be recommended in most hypertensive patients 
with few exceptions. A less strict BP goal may be considered in 
elderly hypertensive patients, particularly in patients older than 
80 years (systolic blood pressure < 150 mmHg), and a lower goal 
may be considered in patients with chronic kidney disease and 
overt proteinuria (systolic blood pressure < 130 mmHg) and in 
diabetic patients (diastolic blood pressure < 85 mmHg). No direct 
evidence is yet available on blood pressure goals for out-of-office 
blood pressure, neither for home blood pressure nor for 
ambulatory blood pressure. 
Pitfalls in the management of hypertension are numerous, mostly 
related to lack of adherence to guidelines by the physician. More 
or less frequently encountered pitfalls include: the use of 
improper cuff size for the measurement of blood pressure; lack of 
consideration of the regression towards the mean phenomenon 
over several visits; overtreatment of patients with white-coat 
hypertension;  undetected masked hypertension; lack of attention 
to lifestyle measures; focus on blood pressure rather than on all 
of the cardiovascular risk factors; physician’s inertia and 
undetected low adherence to treatment. 
